var title_f42_27_43440="Putting on compression stockings PI";
var content_f42_27_43440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Putting on compression stockings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 437px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43440=[""].join("\n");
var outline_f42_27_43440=null;
var title_f42_27_43441="Adenomyosis 6b";
var content_f42_27_43441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sagittal spin-echo T2-weighted MR image",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal spin-echo T2-weighted MR image obtained three months after embolization shows normal junctional zone thickness (arrow). The patient's symptoms improved significantly after uterine fibroid embolization. Follow-up MR of the pelvis one year later showed no changes from 3-month follow-up study and no evidence of recurrence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43441=[""].join("\n");
var outline_f42_27_43441=null;
var title_f42_27_43442="Zipper entrapment release";
var content_f42_27_43442=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cloth cutting to release skin grasped by a zipper",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 529px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The clinician releases the entrapped skin by cutting the cloth as indicated in the figure. Once the cloth is cut, the zipper teeth will easily disengage from the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fein JA, Zderic SA. Management of zipper injuries. In: Textbook of Pediatric Emergency Procedures, 2nd Edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43442=[""].join("\n");
var outline_f42_27_43442=null;
var title_f42_27_43443="Acromegaly";
var content_f42_27_43443=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Acromegaly (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/27/43443/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43443/contributors\" id=\"au7056\">",
"       Shlomo Melmed, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43443/contributors\" id=\"au5918\">",
"       Peter J Snyder, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/27/43443/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43443/contributors\" id=\"se4042\">",
"       David S Cooper, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/27/43443/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43443/contributors\" id=\"de5123\">",
"       Kathryn A Martin, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/27/43443?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ACROMEGALY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Acromegaly is the overgrowth of bodily tissues that causes broadening and enlargement of facial features and an increase in the size of the hands and feet. It is caused by prolonged, excessive secretion of growth hormone (GH). The most common cause of acromegaly is a tumor (adenoma) of the cells that produce growth hormone. These tumors are not cancerous; they are always benign. These cells are within the anterior pituitary gland, located in the middle of the head just below the brain (",
"     <a class=\"graphic graphic_figure graphicRef63094 \" href=\"mobipreview.htm?18/19/18739\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Acromegaly is uncommon; only three to four cases are diagnosed per million people each year. It develops very gradually and may not be recognized until it has been present for many years.",
"    </p>",
"    <p>",
"     Acromegaly can lead to serious illness if not treated; however, most patients can be treated successfully.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ACROMEGALY SIGNS AND SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Excessive production of growth hormone stimulates overproduction of another hormone, called insulin-like growth factor-1 (IGF-1). IGF-1 stimulates the growth of skin, connective tissue, cartilage, bone, organs, and other tissues in the body; an exception is the bones of the arms and legs, which do not continue to grow after middle to late puberty. Other symptoms of acromegaly are caused by the pituitary adenoma, which can compress nearby structures.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Features due to excessive growth hormone",
"     </span>",
"     &nbsp;&mdash;&nbsp;Excessive growth of soft tissue, cartilage, and bone in the face, hands, and feet are the most prominent symptoms of acromegaly.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Face and head &mdash; Facial features (nose, lips, ears, and forehead) become broader and larger and swollen (",
"       <a class=\"graphic graphic_picture graphicRef70185 \" href=\"mobipreview.htm?33/13/34000\">",
"        picture 1",
"       </a>",
"       ), the tongue enlarges, the space between the teeth increases, and the lower jaw grows, resulting in an under bite and extended lower jaw. Headache may be present. Facial hair growth increases, which may be especially bothersome to women. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/24/13698?source=see_link\">",
"        \"Patient information: Hirsutism (excess hair growth in women) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Throat &mdash; Excessive soft tissue growth of the throat and voice box can lead to a hoarse voice or sleep apnea (a condition in which a person stops breathing temporarily during sleep, causing lowered levels of oxygen, disrupted sleep, and daytime sleepiness). (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/25/26003?source=see_link\">",
"        \"Patient information: Sleep apnea in adults (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Hands and feet &mdash; The hands and feet enlarge, often requiring patients to wear larger sized rings, gloves, and shoes (",
"       <a class=\"graphic graphic_picture graphicRef79214 \" href=\"mobipreview.htm?25/40/26240\">",
"        picture 2",
"       </a>",
"       ). Overgrowth of tissues in the wrist can compress nerves to the hands, leading to tingling or pain in the fingers (called carpal tunnel syndrome).",
"      </li>",
"      <li>",
"       Skin &mdash; The skin may thicken and skin tags may appear. Excessive sweating, even while resting, is common.",
"      </li>",
"      <li>",
"       Bones &mdash; Overgrowth of the ends of bones can damage neighboring cartilage and lead to arthritis.",
"      </li>",
"      <li>",
"       Heart &mdash; The incidence of heart disease is increased, likely due to enlargement of the heart muscle, which impairs functioning of the muscle (called cardiomyopathy). High blood pressure is more common in acromegaly. Some people have problems with their heart valves. Heart failure may occur if acromegaly is uncontrolled.",
"      </li>",
"      <li>",
"       Diabetes &mdash; Higher blood glucose levels may be a direct result of excessive growth hormone production. Diabetes is more common in people with acromegaly, and people with previously diagnosed diabetes may require higher doses of medication.",
"      </li>",
"      <li>",
"       Tumors &mdash; Patients with acromegaly have an increased risk of noncancerous (benign) tumors, especially if growth hormone levels are not controlled. Polyps of the colon are more common and can become cancerous if not surgically removed. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/9/25747?source=see_link\">",
"        \"Patient information: Colon polyps (Beyond the Basics)\"",
"       </a>",
"       .) Benign tumors of the uterus (fibroids) are more common in acromegaly. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/20/20804?source=see_link\">",
"        \"Patient information: Uterine fibroids (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Life expectancy may be reduced by approximately 10 years, especially when growth hormone levels are uncontrolled and diabetes and heart disease are present. Patients who are successfully treated for acromegaly and whose growth hormone levels fall to normal generally have a normal life expectancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Features due to the size of the pituitary adenoma",
"     </span>",
"     &nbsp;&mdash;&nbsp;If the pituitary adenoma becomes large (eg, 2 cm [1 inch] or greater), the increased pressure on surrounding structures can cause symptoms.",
"    </p>",
"    <p>",
"     If the adenoma grows upward, it may stretch the nerves of the eyes (optic chiasm), causing vision problems, especially with peripheral (side) vision. These are very rare occurrences in well&ndash;managed patients.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      ACROMEGALY DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     If acromegaly is suspected based upon a person's appearance, the diagnosis must be confirmed by measurement of blood levels of IGF-1",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     growth hormone.",
"    </p>",
"    <p>",
"     The blood level of IGF-1 can be determined in a single blood sample drawn at any time of day. Measurement of a single sample of blood for growth hormone is not helpful in making the diagnosis of acromegaly, but measurement of growth hormone several times before and after drinking a glucose (sugar) solution is helpful.",
"    </p>",
"    <p>",
"     Once excessive growth hormone secretion has been confirmed, magnetic resonance imaging (MRI) is done to determine if an adenoma can be seen in the pituitary.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      ACROMEGALY TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Patients with acromegaly are treated to avoid the risk of the consequences described above, even if there are no obvious symptoms. The goal of therapy is to lower the level of growth hormone and IFG-1 in the blood to normal. If treatment is successful, the soft tissue changes will go away over a period of several months and the risk of early death returns to normal. Sometimes, initial treatment is not entirely successful and additional treatment is needed.",
"    </p>",
"    <p>",
"     There are three main forms of treatment: surgery, medications, and radiation therapy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery offers the chance of a cure if the pituitary tumor can be completely removed, which is most likely in people whose adenoma is small and does not extend outside the normal boundaries of the pituitary. For this reason, surgery is the first choice in this situation. Surgery is also the first choice of treatment when the adenoma is very large and impairing or threatening vision.",
"    </p>",
"    <p>",
"     During surgery, a small incision is made in the nose (",
"     <a class=\"graphic graphic_figure graphicRef75464 \" href=\"mobipreview.htm?43/36/44608\">",
"      figure 2",
"     </a>",
"     ), through which the surgeon is able to visualize and remove adenoma tissue. Neurosurgeons often use a device called an endoscope to see the area around the pituitary better. People who may need surgery should discuss their situation with a neurosurgeon who performs transsphenoidal surgery frequently. Patients should specifically ask about the number of transsphenoidal surgeries done per year; studies suggest that surgeons who perform at least 50 per year have better outcomes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      How well does surgery work?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery is usually effective in reducing growth hormone levels, although levels do not always return to normal. The chance that the growth hormone levels will be normal after surgery is directly related to the size of the adenoma before surgery. The levels of growth hormone and IGF-1 will return to normal in about eighty percent of people with small adenomas (less than 1 cm [0.5 inch]). On the other hand, less than 40 percent of people who have larger adenomas that extend beyond the pituitary will have normal hormone levels after surgery.",
"    </p>",
"    <p>",
"     If the adenoma is completely removed, the blood GH level falls to normal within hours after surgery and the blood IGF-1 level returns to normal within weeks to months.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Complications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Serious complications are uncommon when the procedure is performed by a neurosurgeon highly experienced in pituitary surgery. The chance of serious complications, such as worsening of vision, meningitis, or nasal leakage of spinal fluid is less than 5 percent. The chance of damage to the pituitary gland is about 7 percent; this damage can lead to underactivity of the thyroid gland, adrenal glands, and the ovaries in women and testicles in men.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Three classes of medications are used to treat acromegaly. They work by lowering blood levels of growth hormone or blocking the effects of growth hormone:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Somatostatin analogs (octreotide or lanreotide)",
"      </li>",
"      <li>",
"       Growth hormone receptor antagonist (pegvisomant)",
"      </li>",
"      <li>",
"       Dopamine agonists, especially cabergoline",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Somatostatin analogs",
"     </span>",
"     &nbsp;&mdash;&nbsp;Somatostatin analogs block the release of growth hormone from tumor cells in the pituitary.",
"    </p>",
"    <p>",
"     Octreotide (brand name: Sandostatin&reg;) is used in a long-acting form given every four weeks by injection.",
"    </p>",
"    <p>",
"     Lanreotide (brand name: Somatuline&reg; Depot) is available in a long-acting form given every four weeks by injection.",
"    </p>",
"    <p>",
"     These medications can be used as an initial treatment, especially when an adenoma is too large to remove completely with surgery. They can also be used as secondary treatment for people who have remaining adenoma tissue and an elevated blood growth hormone concentration after transsphenoidal surgery.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Results &mdash; Somatostatin analogs reduce blood concentrations of growth hormone and IGF-1 to some degree in most patients with acromegaly, although levels return to normal in only about half of patients. Somatostatin analogs may also control adenoma growth, or even reduce adenoma size.",
"      </li>",
"      <li>",
"       Side effects &mdash; Somatostatin analogs are usually well-tolerated, but there are possible side effects.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Common side effects include abdominal cramps, abdominal discomfort, bloating, and loose stools during the first month of treatment. These symptoms often occur after the first dose, less often after the second, and uncommonly thereafter.",
"      </li>",
"      <li>",
"       Gallstones develop in about 20 percent of patients within the first six months of treatment. These do not usually require the person to discontinue treatment, except in the small percentage of people who experience inflammation of the gallbladder (cholecystitis). (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/21/7507?source=see_link\">",
"        \"Patient information: Gallstones (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Growth hormone receptor antagonist",
"     </span>",
"     &nbsp;&mdash;&nbsp;The one growth hormone receptor antagonist available (pegvisomant; brand name: Somavert&reg;) blocks the effects of growth hormone by binding to its receptor, decreasing IGF-1 production and thereby decreasing growth. It is given daily by injection.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Results &mdash; More than 90 percent of subjects who are treated with pegvisomant have a lowering of IGF-1 to normal.",
"      </li>",
"      <li>",
"       Side effects &mdash; Reversible liver function abnormalities occur occasionally, so liver tests should be measured periodically. As adenoma size may continue to increase during GH receptor antagonist use in some patients, MRI is recommended once per year to monitor adenoma size.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Dopamine agonists",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dopamine agonists may rarely block growth hormone secretion and, therefore, decrease IGF-1 levels, although they are not usually as effective as other classes of medications. Because they can be taken orally, they are more convenient than other forms of treatment.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Results &mdash; Some studies report that cabergoline reduces the level of growth hormone and IGF-1 to normal in one-third of patients, although most endocrinologists have not found cabergoline to be this successful. Bromocriptine (brand name: Parlodel&reg;) is another dopamine agonist, although it is even less effective and not recommended.",
"      </li>",
"      <li>",
"       Side effects &mdash; The most common side effects of dopamine agents, especially at the higher doses used for acromegaly, are:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Nausea, less likely with cabergoline than bromocriptine",
"      </li>",
"      <li>",
"       Lightheadedness after standing due to a fall in blood pressure",
"      </li>",
"      <li>",
"       Mental fogginess or mood disturbances",
"      </li>",
"      <li>",
"       Fatigue",
"      </li>",
"      <li>",
"       Sinus congestion",
"      </li>",
"      <li>",
"       Bad dreams",
"      </li>",
"      <li>",
"       Constipation, which is uncommon but can be severe",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Side effects, especially nausea, can be minimized by taking the medication with meals or at bedtime and beginning with the lowest dose and increasing gradually.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Radiation therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Radiation therapy has been used for many years for treatment of pituitary adenomas, including those that make growth hormone. Radiation can be delivered in one of several ways:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       A linear accelerator, which delivers x-radiation in multiple small doses over the course of a month or in one or a few large doses.",
"      </li>",
"      <li>",
"       A cobalt source, which delivers gamma radiation only as a single large dose. This radiation is referred to as &ldquo;gamma knife.&rdquo;",
"      </li>",
"      <li>",
"       A cyclotron (proton beam), which delivers protons in multiple small doses or a single large dose.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A single large dose of radiation is used only if the adenoma tissue to be radiated is far enough away from the optic chiasm (nerves to the eyes) that the radiation will not cause damage. Multiple small fractions can be used even if the adenoma is close to the optic chiasm.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Results",
"     </span>",
"     &nbsp;&mdash;&nbsp;Radiation therapy is usually effective in stopping or even reversing adenoma growth and in decreasing growth hormone and IGF-1 production. However, the decline in growth hormone secretion (and clinical improvement) is very slow. Even 10 to 15 years after radiation, only a small percentage of patients achieve a normal blood growth hormone level.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Side effects that occur during or shortly after treatment include fatigue, nausea, loss of scalp hair, and loss of taste and smell. These problems usually resolve within weeks to months after treatment. Damage (called optic neuritis) to the nerve that controls vision can result in blindness, usually in one eye; blindness generally develops between 6 and 24 months after radiation therapy. It is very rare but permanent.",
"    </p>",
"    <p>",
"     Before radiation therapy was delivered stereotactically, blood vessel disease (hardening of the brain arteries) sometimes developed several years after radiation therapy. The risk of cerebral blood vessel disease with or without stroke has been reported to be increased with current radiation therapy delivery methods.",
"    </p>",
"    <p>",
"     Within 10 years after treatment, about 50 percent of patients treated with pituitary radiation develop a deficiency of one or more pituitary hormones, including the hormones that control the thyroid gland, adrenal glands, and ovaries or testicles.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      PREGNANCY AND ACROMEGALY",
"     </span>",
"    </p>",
"    <p>",
"     Little is known about the interaction between acromegaly and pregnancy, although it appears that women are usually able to carry their pregnancy to full term. Reasonable guidelines for women with acromegaly include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Consult an endocrinologist prior to trying to become pregnant. Women should understand which medications will need to be discontinued and what effect acromegaly may have on their individual situation.",
"      </li>",
"      <li>",
"       When pregnancy is confirmed, a woman should speak with her endocrinologist as soon as possible.",
"      </li>",
"      <li>",
"       Visual fields should be monitored during pregnancy in women with adenomas larger than 1 cm (0.5 inch). MRI is recommended if new visual problems develop. MRI is generally thought to be safe for a mother and her fetus during pregnancy if it is performed without the use of gadolinium (dye).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      MONITORING ACROMEGALY",
"     </span>",
"    </p>",
"    <p>",
"     Patients with acromegaly need to be monitored over their lifetime to ensure that treatment is optimal and to minimize the risk of disease complications and treatment side effects. The following should especially be monitored:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Changes in features",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients with acromegaly should note whether treatment improves their symptoms, such as headache or excess perspiration. The patient and",
"     <span class=\"nowrap\">",
"      his/her",
"     </span>",
"     doctor should note whether treatment improves the signs of acromegaly, including enlargement of the face, hands, and feet.",
"    </p>",
"    <p>",
"     Until the blood levels of growth hormone and IGF-1 return to normal, patients and their doctors should be vigilant about treating sleep apnea if it is present. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/25/26003?source=see_link\">",
"      \"Patient information: Sleep apnea in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Because of the increased risk of colon polyps, colonoscopy should be performed every three to four years after age 50 or sooner. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/23/7541?source=see_link\">",
"      \"Patient information: Colon and rectal cancer screening (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Growth hormone and IGF-1 levels",
"     </span>",
"     &nbsp;&mdash;&nbsp;The blood level of IGF-1 should be measured to monitor response to treatment. The goal is to keep the IGF-1 level in the middle of the normal range for the person&rsquo;s age and gender.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Other pituitary hormone levels",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who have acromegaly may produce inadequate amounts of other pituitary hormones because of pressure from the adenoma on the normal pituitary or due to surgery or radiation therapy. Levels of hormones produced by the thyroid gland, adrenal glands, and ovaries or testes should be monitored and replaced as needed.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Size of the adenoma",
"     </span>",
"     &nbsp;&mdash;&nbsp;If the adenoma was initially larger than 1 cm (0.5 inch), it is important to determine if treatment has decreased its size. This is generally done by magnetic resonance imaging (MRI) of the pituitary area.",
"    </p>",
"    <p>",
"     If the initial treatment has not been entirely successful, additional treatments should be considered carefully. Patients with well-controlled disease generally have a lower risk of complications, other underlying medical conditions, and early death.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804575907\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17219409\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/8/40066?source=see_link\">",
"      Patient information: Acromegaly (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/28/7619?source=see_link\">",
"      Patient information: Pituitary adenoma (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/26/17826?source=see_link\">",
"      Patient information: Growth hormone treatment (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17219417\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/24/13698?source=see_link\">",
"      Patient information: Hirsutism (excess hair growth in women) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/25/26003?source=see_link\">",
"      Patient information: Sleep apnea in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/20/20804?source=see_link\">",
"      Patient information: Uterine fibroids (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/9/25747?source=see_link\">",
"      Patient information: Colon polyps (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/21/7507?source=see_link\">",
"      Patient information: Gallstones (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/23/7541?source=see_link\">",
"      Patient information: Colon and rectal cancer screening (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/3/30776?source=see_link\">",
"      Causes and clinical manifestations of acromegaly",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43076?source=see_link\">",
"      Diagnosis of acromegaly",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/9/13464?source=see_link\">",
"      Pituitary gigantism",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7015?source=see_link\">",
"      Rheumatic and bone disorders associated with acromegaly",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/9/7322?source=see_link\">",
"      Treatment of acromegaly",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The National Institute of Diabetes and Digestive and Kidney Disorders",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niddk.nih.gov/\">",
"        www.niddk.nih.gov/",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Hormone Foundation",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.hormone.org/public/pituitary.cfm\">",
"        www.hormone.org/public/pituitary.cfm",
"       </a>",
"       , available in English and Spanish)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?42/27/43443/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/27/43443?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43443/abstract/1\">",
"      Giustina A, Chanson P, Bronstein MD, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010; 95:3141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43443/abstract/2\">",
"      Clemmons DR, Chihara K, Freda PU, et al. Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 2003; 88:4759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43443/abstract/3\">",
"      Melmed S, Casanueva FF, Cavagnini F, et al. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002; 87:4054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43443/abstract/4\">",
"      Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004; 25:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43443/abstract/5\">",
"      Melmed S. Medical progress: Acromegaly. N Engl J Med 2006; 355:2558.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f42_27_43443=[""].join("\n");
var outline_f42_27_43443=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ACROMEGALY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ACROMEGALY SIGNS AND SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           ACROMEGALY DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           ACROMEGALY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           PREGNANCY AND ACROMEGALY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           MONITORING ACROMEGALY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/19/18739\" title=\"figure 1\">",
"           Brain pituitary anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/36/44608\" title=\"figure 2\">",
"           Pituitary surgery PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/13/34000\" title=\"picture 1\">",
"           Acromegaly features PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/40/26240\" title=\"picture 2\">",
"           Hands in acromegaly PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f42_27_43444="Dacarbazine: Patient drug information";
var content_f42_27_43444=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dacarbazine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/49/4887?source=see_link\">",
"     see \"Dacarbazine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/45/22229?source=see_link\">",
"     see \"Dacarbazine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F156223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dacarbazine for Injection",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700696",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems in some patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug can cause cancer in animals. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4090502",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may irritate the vein. It may burn the skin if the drug leaks from the vein when it is given. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dacarbazine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, bright indoor lights, and tanning beds. Wear clothing and eyewear that protects you from the sun. Sunscreens will not protect you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698359",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sunburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation or swelling where the shot was given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3756462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood pressure can happen if the shot is given too fast.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12480 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-62FEFCC119-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43444=[""].join("\n");
var outline_f42_27_43444=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156223\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018861\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018863\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018862\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018867\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018868\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018870\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018865\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018872\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?4/49/4887?source=related_link\">",
"      Dacarbazine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/45/22229?source=related_link\">",
"      Dacarbazine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_27_43445="Levalbuterol: Drug information";
var content_f42_27_43445=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levalbuterol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/7/22645?source=see_link\">",
"    see \"Levalbuterol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/52/18245?source=see_link\">",
"    see \"Levalbuterol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xopenex HFA&trade;;",
"     </li>",
"     <li>",
"      Xopenex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xopenex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F187544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Beta",
"      <sub>",
"       2",
"      </sub>",
"      Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F187529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Bronchospasm:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Metered-dose inhaler:",
"     </i>",
"     2 puffs every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Solution for nebulization:",
"     </i>",
"     0.63 mg 3 times/day at intervals of 6-8 hours; dosage may be increased to 1.25 mg 3 times/day with close monitoring for adverse effects",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Exacerbation of asthma (acute, severe)",
"     </b>",
"     <b>",
"      <i>",
"       (NIH Guidelines, 2007):",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Metered-dose inhaler:",
"     </i>",
"     4-8 puffs every 20 minutes for up to 4 hours, then every 1-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Solution for nebulization:",
"     </i>",
"     1.25-2.5 mg every 20 minutes for 3 doses, then 1.25-5 mg every 1-4 hours as needed",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F187538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/52/18245?source=see_link\">",
"      see \"Levalbuterol: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Bronchospasm:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Metered-dose inhaler:",
"     </i>",
"     Children &ge;4 years: 2 puffs every 4-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Solution for nebulization:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children &le;4 years (NIH Guidelines, 2007): 0.31-1.25 mg every 4-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children 5-11 years (NIH Guidelines, 2007): 0.31-0.63 mg 3 times/day as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children &ge;12 years: 0.63-1.25 mg every 8 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Exacerbation of asthma (acute, severe)",
"     </b>",
"     <b>",
"      <i>",
"       (NIH Guidelines, 2007):",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Metered-dose inhaler:",
"     </i>",
"     Children &ge;4 years: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:6em;\">",
"     <i>",
"      Solution for nebulization:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:8em;\">",
"     Children &lt;12 years: 0.075 mg/kg (minimum: 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg (maximum: 5 mg) every 1-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:8em;\">",
"     Children &ge;12 years: 1.25-2.5 mg every 20 minutes for 3 doses, then 1.25-5 mg every 1-4 hours as needed",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F187530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Only a small number of patients have been studied. Although greater sensitivity of some elderly patients cannot be ruled out, no overall differences in safety or effectiveness were observed. An initial dose of 0.63 mg should be used in all patients &gt;65 years of age.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16160291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling. Use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16160292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187503\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, for oral inhalation, as tartrate [strength expressed as base]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xopenex HFA&trade;: 45 mcg/actuation (15 g) [chlorofluorocarbon free; 200 actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, for nebulization, as hydrochloride [strength expressed as base, preservative free]: 0.31 mg/3 mL (24s); 0.63 mg/3 mL (24s); 1.25 mg/3 mL (24s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xopenex&reg;: 0.31 mg/3 mL (24s); 0.63 mg/3 mL (24s); 1.25 mg/3 mL (24s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, for nebulization, as hydrochloride [strength expressed as base, concentrate, preservative free]: 1.25 mg/0.5 mL (30s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes aerosol",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F187506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metered-dose inhaler: Shake well before use; prime with 4 test sprays prior to first use or  if inhaler has not been used for more than 3 days. Clean actuator (mouthpiece) weekly. A spacer device or valved holding chamber  is recommended when using a metered-dose inhaler.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for nebulization: Safety and efficacy were established when administered with the following nebulizers: PARI LC Jet&trade;, PARI LC Plus&trade;, as well as the following compressors: PARI Master&reg;, Dura-Neb&reg; 2000, and Dura-Neb&reg; 3000. Concentrated solution should be diluted prior to use. Blow-by administration is not recommended, use a mask device if patient unable to hold mouthpiece in mouth for administration.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F5521766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Solution for nebulization:",
"     <b>",
"      Compatible",
"     </b>",
"     with budesonide suspension",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F187504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment or prevention of bronchospasm in children and adults  with reversible obstructive airway disease",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Xopenex&reg; may be confused with Xanax&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F187542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Serum glucose increased, serum potassium decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor (&le;7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis (3% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Viral infection (7% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;2% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (8% to 12%), nervousness (3% to 10%), dizziness (1% to 3%), anxiety (&le;3%), migraine (&le;3%), weakness (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Tachycardia (&sim;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (&le;8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (2% to 6%), dyspepsia (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Leg cramps (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Asthma (9%), pharyngitis (3% to 10%), cough (1% to 4%), sinusitis (1% to 4%), nasal edema (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (1% to 4%), accidental injury (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;2% (Limited to important or life-threatening): Abnormal ECG, acne, anaphylaxis, angina, angioedema, arrhythmia, atrial fibrillation, chest pain, chills, constipation, conjunctivitis, cough, diaphoresis, dysmenorrhea, dyspnea, epistaxis, extrasystole, gastroenteritis, hematuria, hyper-/hypotension, hypoesthesia (hand), hypokalemia, insomnia, itching eyes, lymphadenopathy, metabolic acidosis, myalgia, nausea, oropharyngeal dryness, paresthesia, supraventricular arrhythmia, syncope, vaginal moniliasis, vertigo, vomiting, wheezing, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Immediate hypersensitivity reactions have occurred (including angioedema, oropharyngeal edema, urticaria, and anaphylaxis).",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F187509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to levalbuterol, albuterol, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F187492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchospasm: Rarely, paradoxical bronchospasm may occur with use of inhaled bronchodilating agents; this should be distinguished from inadequate response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Immediate hypersensitivity reactions (urticaria, angioedema, rash, bronchospasm) have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Appropriate use: Optimize anti-inflammatory treatment before initiating maintenance treatment with levalbuterol. Do not use as a component of chronic therapy without an anti-inflammatory agent. Only the mildest form of asthma (Step 1 and/or exercise-induced) would not require concurrent use based upon asthma guidelines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (arrhythmia or hypertension or HF); beta-agonists may cause elevation in blood pressure, heart rate and result in CNS stimulation/excitation. Beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists may also increase risk of arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists may increase serum glucose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with glaucoma; may elevate intraocular pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use with caution in hyperthyroidism; may stimulate thyroid activity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypokalemia: Use with caution in patients with hypokalemia; beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists may decrease serum potassium.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients with seizure disorders; beta-agonists may result in CNS stimulation/excitation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children &lt;4 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Do not exceed recommended dose; serious adverse events, including fatalities, have been associated with excessive use of inhaled sympathomimetics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Patient information: Patients must be instructed to seek medical attention in cases where acute symptoms are not relieved or a previous level of response is diminished. The need to increase frequency of use may indicate deterioration of asthma, and treatment must not be delayed. A spacer device or valved holding chamber is recommended when using a metered-dose inhaler.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F187497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Blockers: May diminish the therapeutic effect of Beta2-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the tachycardic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atosiban: Beta2-Agonists may enhance the adverse/toxic effect of Atosiban. Specifically, there may be an increased risk for pulmonary edema and/or dyspnea.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Beta1 Selective): May diminish the bronchodilatory effect of Beta2-Agonists. Of particular concern with nonselective beta-blockers or higher doses of the beta1 selective beta-blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Nonselective): May diminish the bronchodilatory effect of Beta2-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: May diminish the therapeutic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Beta2-Agonists may enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Beta2-Agonists may enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F187512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies; however, racemic albuterol was teratogenic in some species. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if benefit exceeds risk. Use caution if needed for bronchospasm during labor and delivery; has potential to interfere with uterine contractions.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F187533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F187513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known whether levalbuterol is excreted in human milk. Plasma levels following oral inhalation are low. Racemic albuterol was shown to be tumorigenic in animal studies.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F187511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Aerosol",
"     </b>",
"     (Xopenex HFA Inhalation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     45 mcg/ACT (15 g): $57.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nebulization",
"     </b>",
"     (Levalbuterol HCl Inhalation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.31 mg/3 mL (3 mL): $6.71",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.63 mg/3 mL (3 mL): $6.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.25 mg/0.5 mL (1): $6.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.25 mg/3 mL (3 mL): $6.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nebulization",
"     </b>",
"     (Xopenex Concentrate Inhalation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.25 mg/0.5 mL (30): $223.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nebulization",
"     </b>",
"     (Xopenex Inhalation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.31 mg/3 mL (3 mL): $7.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.63 mg/3 mL (3 mL): $7.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.25 mg/3 mL (3 mL): $7.45",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F187501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Asthma symptoms; FEV",
"     <sub>",
"      1",
"     </sub>",
"     , peak flow, and/or other pulmonary function tests; heart rate, blood pressure, CNS stimulation; arterial blood gases (if condition warrants); serum potassium, serum glucose (in selected patients)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F12707686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Seramar (CO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F187491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relaxes bronchial smooth muscle by action on beta",
"     <sub>",
"      2",
"     </sub>",
"     -receptors with little effect on heart rate",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F187508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action (as measured by a 15% increase in FEV",
"     <sub>",
"      1",
"     </sub>",
"     ):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Aerosol: 5.5-10.2 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Peak effect: &sim;77 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Nebulization: 10-17 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Peak effect: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration (as measured by a 15% increase in FEV",
"     <sub>",
"      1",
"     </sub>",
"     ):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Aerosol: 3-4 hours (up to 6 hours in some patients)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Nebulization: 5-6 hours (up to 8 hours in some patients)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: A portion of inhaled dose is absorbed to systemic circulation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 3.3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Aerosol: Children: 0.8 hours, Adults: 0.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Nebulization: Children: 0.3-0.6 hours, Adults: 0.2 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Expert Panel Report 3, &ldquo;Guidelines for the Diagnosis and Management of Asthma,&rdquo;",
"      <i>",
"       Clinical Practice Guidelines",
"      </i>",
"      , National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm",
"      </a>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10215 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-5DB5CB92DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43445=[""].join("\n");
var outline_f42_27_43445=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187525\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187526\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187544\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187529\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187538\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187530\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160291\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160292\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187503\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187488\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187506\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5521766\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187504\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187551\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187542\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187509\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187492\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299585\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187497\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187499\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187512\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187533\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187513\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187511\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187501\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12707686\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187491\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187508\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10215\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10215|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/7/22645?source=related_link\">",
"      Levalbuterol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/52/18245?source=related_link\">",
"      Levalbuterol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_27_43446="Primary biliary cirrhosis XI - high power";
var content_f42_27_43446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary biliary cirrhosis in a woman who presented with pruritus, one year after treatment with methotrexate (high power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are several normal bile ducts and slight hepatic steatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43446=[""].join("\n");
var outline_f42_27_43446=null;
var title_f42_27_43447="Anatomy of the chest wall and axilla";
var content_f42_27_43447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F54961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F54961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 610px\">",
"   <div class=\"ttl\">",
"    Anatomy of the chest wall and axilla",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 590px; height: 495px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Topographic anatomic depiction of levels I, II, and III of the axillary contents with relation to the neurovascular bundle, pectoralis minor, latissimus dorsi, posterior axillary space, and chest wall. Level I comprises three principal axillary nodal groups: the external mammary group, the subscapular group, and the axillary vein (lateral) group. Level II, the central nodal group, is centrally placed immediately beneath the pectoralis minor muscle. The subclavicular (apical) group is designated level III nodes and is superomedial to the pectoralis minor muscle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bland KI. Modified radical mastectomy and total (simple) mastectomy. In: Master Techniques in General Surgery: Breast Surgery, Bland KI, Klimberg SV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43447=[""].join("\n");
var outline_f42_27_43447=null;
var title_f42_27_43448="Mechanisms of glomerular crescent formation";
var content_f42_27_43448=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of glomerular crescent formation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     Pierre Ronco, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43448/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/27/43448/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cellular glomerular crescents are defined as",
"    <strong>",
"     two or more layers of proliferating cells in Bowman's space",
"    </strong>",
"    (",
"    <a class=\"graphic graphic_picture graphicRef68861 \" href=\"mobipreview.htm?21/27/21945\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef76472 \" href=\"mobipreview.htm?21/55/22393\">",
"     picture 2",
"    </a>",
"    ) and are a hallmark of inflammatory glomerulonephritis and a histologic marker of",
"    <strong>",
"     severe glomerular injury",
"    </strong>",
"    . In general, the severity of the renal failure and other clinical manifestations of glomerulonephritis (eg, hypertension, edema) correlates with the percentage of glomeruli that exhibit crescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. The duration and potential reversibility of the underlying disease correspond with the relative predominance of cellular or fibrous components in the crescents. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Course of crescents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Crescentic glomerulonephritis is typically associated with the syndrome of rapidly progressive glomerulonephritis, which can occur in most forms of inflammatory glomerular injury, including postinfectious glomerulonephritis, IgA nephropathy, lupus nephritis, renal vasculitis, membranoproliferative glomerulonephritis, and anti-glomerular basement membrane (GBM) antibody disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=see_link&amp;anchor=H9#H9\">",
"     \"Differential diagnosis and evaluation of glomerular disease\", section on 'Moderate to severe glomerulonephritis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review the mechanisms of glomerular crescent formation. The classification, clinical presentation, evaluation, diagnosis, and treatment of crescentic glomerulonephritis, as well as the mechanisms and pathogenesis of glomerular injury, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18231?source=see_link\">",
"     \"Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18921?source=see_link\">",
"     \"Mechanisms of immune injury of the glomerulus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40261?source=see_link\">",
"     \"Pathogenesis of tissue injury in glomerulonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIATING EVENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glomerular crescent formation appears to represent a nonspecific response to severe injury to the glomerular capillary wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/5\">",
"     5",
"    </a>",
"    ]. The initiating event is the development of physical gaps (also called rents or holes) in the glomerular capillary wall, glomerular basement membrane, and Bowman's capsule (",
"    <a class=\"graphic graphic_picture graphicRef76472 \" href=\"mobipreview.htm?21/55/22393\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef78020 \" href=\"mobipreview.htm?24/56/25480\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These gaps permit the entry into Bowman's space of coagulation factors, which lead to fibrin formation (due to conversion of fibrinogen to fibrin polymers and delayed fibrinolysis) and cellular elements (such as monocytes and lymphocytes), both of which promote crescent formation (",
"    <a class=\"graphic graphic_picture graphicRef78020 \" href=\"mobipreview.htm?24/56/25480\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/5,8\">",
"     5,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon experimental murine studies, crescent formation is believed to be primarily mediated by a T helper 1 (Th1) nephritogenic immune response involving CD4+ T cells, macrophages, and fibrin as effectors of cell-mediated immunity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/9\">",
"     9",
"    </a>",
"    ]. Th17 CD4 effector cells also appear to play an important role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/10,11\">",
"     10,11",
"    </a>",
"    ] with a potential cytokine-chemokine-driven cross-regulation of Th1 and Th17 subpopulations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/12\">",
"     12",
"    </a>",
"    ]. Recruitment of Th1 is also controlled by regulatory T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=see_link\">",
"     \"T helper subsets: Differentiation and role in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540827538\">",
"    <span class=\"h1\">",
"     FORMATION AND COMPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disruption of the integrity of the glomerular capillary wall with severe glomerular injury initiates a series of events that can result in crescent formation. These factors, which are discussed in detail in the following sections, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rents in the glomerular capillary wall and glomerular basement membrane allow circulating cells, mostly macrophages and T cells, inflammatory mediators, and plasma proteins, particularly coagulation proteins, to pass through the capillary wall and basement membrane and into Bowman's space.",
"     </li>",
"     <li>",
"      The contents in Bowman's space can enter the interstitium, contributing to periglomerular inflammation.",
"     </li>",
"     <li>",
"      Crescent formation results from the subsequent participation of coagulation factors, particularly fibrin; tissue factor, which promotes fibrin deposition; and several different cell types, including macrophages, glomerular parietal epithelial cells, glomerular visceral epithelial cells (podocytes), renal progenitor cells, and interstitial fibroblasts.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, limited data from experimental studies have identified other factors that may contribute to crescent formation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stimulation of toll-like receptor 4 (TLR4) or 9 (TLR9) can promote the development of crescentic glomerulonephritis by effects on both the adaptive and innate immune response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. TLR4 has a crucial direct effect on renal cells.",
"     </li>",
"     <li>",
"      Genetically determined differences in both glomerular and bone marrow-derived cells can influence individual susceptibility to crescent formation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Coagulation proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;A central feature of crescent formation is the presence in Bowman's space of coagulation factors that lead to the cross-linking of fibrin and a deficiency in fibrinolytic mechanisms, both of which can facilitate fibrin deposition (",
"    <a class=\"graphic graphic_picture graphicRef57096 \" href=\"mobipreview.htm?17/11/17599\">",
"     picture 4",
"    </a>",
"    ). The importance of fibrin is illustrated by the findings in animal models that defibrination can prevent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/18\">",
"     18",
"    </a>",
"    ] or reverse crescent formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissue factor, tissue factor inhibitor, thrombin, and the",
"    <span class=\"nowrap\">",
"     plasminogen/plasmin",
"    </span>",
"    system are procoagulant molecules that are central to this process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Tissue factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary stimulus to fibrin deposition in crescent formation appears to be tissue factor, which binds to and activates factor VII [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/20\">",
"     20",
"    </a>",
"    ]. Tissue factor is derived from endothelial cells, glomerular visceral epithelial cells (podocytes), and macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In addition, macrophage-derived interleukin-1 and tumor necrosis factor (TNF) stimulate tissue factor production by glomerular endothelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In early glomerulonephritis, tissue factor expression appears to derive from intrinsic glomerular cells; later, it primarily originates from macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Glomerular visceral epithelial cells (podocytes)'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8\">",
"     'Macrophages'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Tissue factor pathway inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accompanying the increase in tissue factor activity is an early reduction in tissue factor pathway inhibitor (TFPI), which also favors fibrin deposition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/23\">",
"     23",
"    </a>",
"    ]. This early response is followed by enhancement of TFPI expression in later stage disease, chronically inhibiting the deposition of fibrin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A similar effect can be induced by the administration of recombinant TFPI which, in experimental crescentic glomerulonephritis, reduces both fibrin deposition and crescent formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181098138\">",
"    <span class=\"h3\">",
"     Thrombin",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important role for thrombin in crescent formation was suggested in a mouse model in which hirudin, a selective thrombin antagonist, or the absence of protease-activated receptor 1, a cellular thrombin receptor, significantly reduced both glomerular crescent formation and macrophage and T-cell infiltration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Macrophages'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9\">",
"     'T cells'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Plasminogen/plasmin system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     plasminogen/plasmin",
"    </span>",
"    system plays a central role in fibrinolysis and the",
"    <strong>",
"     resolution",
"    </strong>",
"    of glomerular crescents. In experimental and human crescentic glomerulonephritis, there is",
"    <strong>",
"     decreased",
"    </strong>",
"    fibrinolytic activity due to both a reduction in tissue-type plasminogen activator and an increase in plasminogen activator inhibitor-1 (PAI-1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. The end result is that extraglomerular fibrin cross-linking occurs in Bowman's space. Fibrin is a potent chemotactic factor that also helps recruit macrophages into the glomeruli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Macrophages'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Protease-activated receptor-2 (PAR-2), which is a cellular receptor in glomerular cells and macrophages, aggravates experimental crescentic glomerulonephritis due to both augmentation of renal PAI-1 expression and inhibition of matrix metalloproteinase-9 activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/30\">",
"     30",
"    </a>",
"    ]. In contrast, mice lacking PAR-2 have reductions in PAI activity, fibrin deposition, and crescent formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Macrophages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrophages play a central role in the formation of glomerular crescents since both tissue factor expression and fibrin deposition are macrophage-dependent phenomena [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/31\">",
"     31",
"    </a>",
"    ]. In an experimental model of anti-glomerular basement membrane (GBM) antibody-induced glomerulonephritis, macrophages accounted for 42 percent of cells in early crescents and 64 to 71 percent of cells in advanced cellular or fibrocellular crescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Macrophages in the glomeruli presumably derive from the circulation and also probably enter from the periglomerular interstitium via gaps in Bowman's capsule. These gaps may be caused by inflammatory processes similar to those that result in rupture of the glomerular basement membrane (",
"    <a class=\"graphic graphic_picture graphicRef78020 \" href=\"mobipreview.htm?24/56/25480\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    by cell-mediated mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Initiating events'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Localization of macrophages to the glomeruli in crescentic glomerulonephritis involves multiple chemoattractants. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The C-C chemokines macrophage chemoattractant protein-1 (MCP-1), macrophage inhibitory factor (MIF), macrophage inflammatory protein-1-alpha (MIP-1-alpha), and osteopontin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/35-38\">",
"       35-38",
"      </a>",
"      ]. Expression of chemokine receptor 2B (CCR2B), which is the receptor for MCP-1, may be particularly important [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Adhesion molecules, such as vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, and CD44, which are all expressed on glomerular parietal epithelial cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/40,41\">",
"       40,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Renal cell-derived granulocyte-macrophage colony stimulating factor (GM-CSF) may increase expression of VCAM-1, MCP-1, and interleukin (IL)-1 beta, thereby promoting crescent formation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once localized to Bowman's space, activated macrophages contribute to crescent formation by proliferating and by releasing the following molecules:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tissue factor. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Tissue factor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Interleukin (IL)-1 and TNF upregulate adhesion molecule expression, stimulate cell proliferation, and recruit more macrophages [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/32\">",
"       32",
"      </a>",
"      ]. Selective blockade of IL-1 with IL-1 receptor antagonists [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/43\">",
"       43",
"      </a>",
"      ] or of TNF with anti-TNF antibodies or soluble TNF receptors markedly reduces crescent formation in experimental models [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. In contrast to the macrophage origin of most inflammatory mediators, some evidence suggests that the principal source of TNF may be intrinsic renal cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Transforming growth factor (TGF)-beta may play an important role in both disease activity and the transition from cellular to fibrocellular and fibrous crescents since it is a potent stimulus to the production of collagen I [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/47\">",
"       47",
"      </a>",
"      ]. With respect to disease activity, TGF-beta signaling appears to play an important role in the development and progression of crescentic glomerulonephritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/48\">",
"       48",
"      </a>",
"      ]. Further support comes from a study of 15 patients with crescentic glomerulonephritis in which higher urinary TGF-beta levels were associated with a lower likelihood of response to immunosuppressive therapy, possibly reflecting more severe disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/49\">",
"       49",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      With respect to the development of fibrotic disease, an important role for TGF-beta was suggested in a rat model of glomerulonephritis in which administration of a chimeric soluble TGF receptor that binds to and inhibits the actions of TGF-beta reduced extracellular matrix accumulation in the glomeruli [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/50\">",
"       50",
"      </a>",
"      ]. A reduction in extracellular matrix accumulation has also been demonstrated in other studies by inhibiting TGF-beta expression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/51\">",
"       51",
"      </a>",
"      ] or activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The mannose receptor, a pattern recognition receptor implicated in the uptake of endogenous and microbial ligands, is upregulated on activated macrophages. Mannose receptor-deficient mice were protected from crescentic glomerulonephritis in a mouse nephrotoxic nephritis model despite humoral and T-cell responses similar to those of wild-type mice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/53\">",
"       53",
"      </a>",
"      ]. These data suggest that blocking the receptor might provide a more specific approach than broad-based immunosuppressive therapy.",
"     </li>",
"     <li>",
"      Several studies in patients with crescentic glomerulonephritis found increased glomerular expression of matrix metalloproteinases (MMP)-2, 3, 9, and 11 and tissue inhibitor of metalloproteinases (TIMP)-1, which correlated with cellular crescents and disease activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. In experimental studies, MMP-9 protects against experimental crescentic glomerulonephritis through its fibrinolytic activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/30,56\">",
"       30,56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     T cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;T cells are found in Bowman's space and in crescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/33,57\">",
"     33,57",
"    </a>",
"    ]. Localization of T helper cells to the glomeruli may involve a variety of factors. These include traditional chemoattractants (such as monocyte chemoattractant protein [MCP] and macrophage inflammatory protein [MIP]-1-alpha), certain cytokines (such as interleukin [IL]-12p40 and IL-18), mast cells, and costimulatory ligands on macrophages and non-lymphoid cells (such as CD80 and CD86) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. Some of these cytokines may also stimulate production of proinflammatory cytokines such as interferon-gamma and TNF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of T cells in glomerular injury may be related to antigen recognition and macrophage recruitment via the release of factors such as MIF and interferon-gamma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/9,61\">",
"     9,61",
"    </a>",
"    ]. In addition, a possible role for voltage-gated potassium channel Kv1.3, which is expressed on effector memory T cells, was proposed in a rat model of GBM crescentic glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/62\">",
"     62",
"    </a>",
"    ]. In addition to effector memory T cells, Kv1.3 channels were also expressed on some macrophages and in the glomeruli. Administration of a Kv1.3 blocker was associated with fewer crescents and less proteinuria than in rats given the vehicle alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glomerular parietal epithelial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glomerular parietal epithelial cells are significant constituents of crescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Unlike glomerular visceral epithelial cells (podocytes), which are normally terminally differentiated cells with little proliferative capacity (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Glomerular visceral epithelial cells (podocytes)'",
"    </a>",
"    below), glomerular parietal epithelial cells can and do proliferate, presumably in response to growth factors, such as platelet-derived growth factor and fibroblast growth factor-2 (basic fibroblast growth factor) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/29\">",
"     29",
"    </a>",
"    ]. Studies performed in a mouse model using genetic tagging of glomerular parietal epithelial cells demonstrated the significant contribution of these cells to crescent formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since glomerular parietal epithelial cells are not major sources of procoagulant molecules or growth factors, it is unlikely that they are as important as macrophages and interstitial fibroblasts (as described above) in determining the course and consequences of crescent formation. However, glomerular parietal epithelial cells can undergo dysregulation and become macrophage-like inflammatory effector cells and may be the primary cells producing type I collagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Glomerular visceral epithelial cells (podocytes)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glomerular visceral epithelial cells (podocytes) (",
"    <a class=\"graphic graphic_figure graphicRef70765 \" href=\"mobipreview.htm?19/50/20259\">",
"     figure 1",
"    </a>",
"    ) were considered to be terminally differentiated cells and had not been regarded as participants in crescent formation. However, lineage tagging experiments showed that new podocytes could be recruited from glomerular parietal epithelial cells through differentiation and proliferation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/67\">",
"     67",
"    </a>",
"    ]. Evidence supporting the contribution of podocytes to crescent formation was provided by studies in murine models of and humans with GBM antibody disease in which podocytes adhered to both the glomerular basement membrane and the parietal basement membrane, forming podocyte bridges between the glomerular tuft and Bowman's capsule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. It has been suggested that podocyte bridging may be an important event that occurs early in the development of crescentic glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Podocytes also populate crescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/69,70\">",
"     69,70",
"    </a>",
"    ] and may undergo epithelial mesenchymal transformation to contribute to crescent formation, particularly in early disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. The following observations provide support for these findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nestin, a marker for the metanephric blastema that gives rise to podocytes, has been identified in crescents of kidney biopsies from patients with crescentic glomerulonephritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genetically tagged podocytes are an important component of cellular crescents in a murine model of anti-GBM antibody disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In mice, selective deletion of the Von Hippel-Lindau gene in glomeruli leads to clinical evidence of glomerulonephritis and spontaneous formation of crescent-like structures that are composed primarily of podocytes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      De novo induction of heparin-binding epidermal growth factor-like growth factor (HB-EGF) has been demonstrated in podocytes in both mice and humans with crescentic glomerulonephritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/74\">",
"       74",
"      </a>",
"      ]. In addition, deficiency or conditional deletion of the epidermal growth factor receptor (EGFR) gene from podocytes of mice alleviates the severity of anti-GBM nephritis, suggesting an autocrine loop that involves induction of HB-EGF in podocytes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/74\">",
"       74",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      De novo expression of HB-EGF in podocytes is also found in crescentic glomerulonephritis in humans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/74,75\">",
"       74,75",
"      </a>",
"      ]. This observation raises the possibility of new therapies since EGFR inhibitors (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/48/6918?source=see_link\">",
"       panitumumab",
"      </a>",
"      ) are clinically available for use in selected patients with cancer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7074941\">",
"    <span class=\"h2\">",
"     Renal progenitor cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal progenitor cells localized in Bowman's capsule are capable of regenerating podocytes. These cells are identified by stem cell markers CD133 and CD24 and are in various stages of differentiation. Different types of progenitor cells seem to be located at the vascular and urinary poles, [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/76\">",
"     76",
"    </a>",
"    ]. Data obtained in human crescentic glomerulonephritis suggest that crescent formation may primarily result from dysregulated proliferation of renal progenitor cells in response to the injured podocyte [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17198248\">",
"    <span class=\"h2\">",
"     Interstitial fibroblasts",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some models of experimental crescentic glomerulonephritis, interstitial fibroblasts are the second most prominent cell type after macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These cells are believed to enter Bowman's space from the periglomerular interstitium through gaps in Bowman's capsule. In the crescent, the fibroblast is a major source of interstitial collagen, which characterizes the transition from cellular to fibrous crescents. Fibroblast proliferation is thought to be growth factor-dependent, probably involving basic fibroblast growth factor (also called fibroblast growth factor-2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/29,78\">",
"     29,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     COURSE OF CRESCENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of crescents does",
"    <strong>",
"     not",
"    </strong>",
"    necessarily predict irreversible glomerular damage. In IgA nephropathy, for example, there may be crescents in a small proportion of glomeruli (usually less than 25 percent) during episodes of gross hematuria and acute worsening of renal function, but the lesions resolve in most patients with little or no scarring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]. This lack of progression occurs when the crescents are predominantly cellular, without a significant fibroblast or collagen component. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/7/42106?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment and prognosis of IgA nephropathy\", section on 'Acute renal failure with gross hematuria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether crescents progress or resolve may depend upon the integrity of Bowman's capsule and the cellular composition of the crescent. Production of interstitial collagen and progression to fibrous crescents are more common when",
"    <strong>",
"     capsular rupture",
"    </strong>",
"    occurs and fibroblasts and macrophages are prominent in Bowman's space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17198248\">",
"     'Interstitial fibroblasts'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Macrophages'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although the presence of fibrous crescents generally correlates with glomerular sclerosis, there is no evidence that events in the crescents cause injury to the glomerular capillaries. As an example, defibrination abolishes crescent formation in animal models without improving renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Thus, crescent formation appears to be",
"    <strong>",
"     a consequence, not a cause",
"    </strong>",
"    , of severe glomerular injury. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Initiating events'",
"    </a>",
"    above.) However, there is increasing evidence that large crescents may occlude the outlet from Bowman's capsule to the proximal tubule to produce \"atubular glomeruli\" with subsequent degeneration of both glomeruli and tubules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43448/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment and prognosis of the renal disease varies with disease severity and the cause of the glomerulonephritis. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18231?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10381717\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cellular glomerular crescents are defined as two or more layers of proliferating cells in Bowman's space (",
"      <a class=\"graphic graphic_picture graphicRef68861 \" href=\"mobipreview.htm?21/27/21945\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef76472 \" href=\"mobipreview.htm?21/55/22393\">",
"       picture 2",
"      </a>",
"      ) and are a hallmark of inflammatory glomerulonephritis and a histologic marker of severe glomerular injury. In general, the severity of the renal failure and other clinical manifestations of glomerulonephritis (eg, hypertension, edema) correlates with the percentage of glomeruli that exhibit crescents. Crescentic glomerulonephritis is typically associated with the syndrome of rapidly progressive glomerulonephritis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction and definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Glomerular crescent formation appears to represent a nonspecific response to severe injury to the glomerular capillary wall. The initiating event is the development of physical gaps (also called rents or holes) in the glomerular capillary wall, glomerular basement membrane, and Bowman's capsule (",
"      <a class=\"graphic graphic_picture graphicRef76472 \" href=\"mobipreview.htm?21/55/22393\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef78020 \" href=\"mobipreview.htm?24/56/25480\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initiating events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rents in the glomerular capillary wall and glomerular basement membrane allow circulating cells, mostly macrophages and T cells, inflammatory mediators, and plasma proteins, particularly coagulation proteins, to pass through the capillary wall and basement membrane and into Bowman's space. The contents in Bowman's space can enter the interstitium, contributing to periglomerular inflammation. Crescent formation results from the participation of these factors (see",
"      <a class=\"local\" href=\"#H540827538\">",
"       'Formation and composition'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Coagulation factors, particularly fibrin and tissue factor (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Coagulation proteins'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Macrophages (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Macrophages'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      T cells (see",
"      <a class=\"local\" href=\"#H9\">",
"       'T cells'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Glomerular parietal epithelial cells (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Glomerular parietal epithelial cells'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Glomerular visceral epithelial cells (podocytes) (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Glomerular visceral epithelial cells (podocytes)'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Renal progenitor cells (see",
"      <a class=\"local\" href=\"#H7074941\">",
"       'Renal progenitor cells'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Interstitial fibroblasts (see",
"      <a class=\"local\" href=\"#H17198248\">",
"       'Interstitial fibroblasts'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of crescents does not necessarily predict irreversible glomerular damage. The potential reversibility of the injury corresponds in part with the relative predominance of cellular versus fibrous components in the crescents. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Course of crescents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1045895527\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors would like to thank Dr. William Couser, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/1\">",
"      Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 2001; 16 Suppl 5:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/2\">",
"      Morrin PA, Hinglais N, Nabarra B, Kreis H. Rapidly progressive glomerulonephritis. A clinical and pathologic study. Am J Med 1978; 65:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/3\">",
"      Whitworth JA, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron 1976; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/4\">",
"      Couser WG. Glomerulonephritis. Lancet 1999; 353:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/5\">",
"      Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/6\">",
"      Lan HY, Nikolic-Paterson DJ, Atkins RC. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest 1992; 67:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/7\">",
"      Morel-Maroger Striker L, Killen PD, Chi E, Striker GE. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 1984; 51:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/8\">",
"      Bonsib SM. Glomerular basement membrane discontinuities. Scanning electron microscopic study of acellular glomeruli. Am J Pathol 1985; 119:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/9\">",
"      Kitching AR, Holdsworth SR, Tipping PG. IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol 1999; 10:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/10\">",
"      Hopfer H, Holzer J, H&uuml;nem&ouml;rder S, et al. Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis. Kidney Int 2012; 82:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/11\">",
"      Summers SA, Steinmetz OM, Li M, et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009; 20:2518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/12\">",
"      Paust HJ, Turner JE, Riedel JH, et al. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 2012; 82:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/13\">",
"      Paust HJ, Ostmann A, Erhardt A, et al. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int 2011; 80:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/14\">",
"      Giorgini A, Brown HJ, Sacks SH, Robson MG. Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells. Am J Pathol 2010; 177:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/15\">",
"      Summers SA, Steinmetz OM, Ooi JD, et al. Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am J Pathol 2010; 177:2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/16\">",
"      Smith J, Lai PC, Behmoaras J, et al. Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol 2007; 18:1816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/17\">",
"      Tipping PG. Crescentic nephritis--is it in your genes? Nephrol Dial Transplant 2008; 23:3065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/18\">",
"      Naish P, Penn GB, Evans DJ, Peters DK. The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 1972; 42:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/19\">",
"      Thomson NM, Moran J, Simpson IJ, Peters DK. Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int 1976; 10:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/20\">",
"      Tipping PG, Erlich JH, Apostolopoulos J, et al. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol 1995; 147:1736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/21\">",
"      Tipping PG, Holdsworth SR. T cells in glomerulonephritis. Springer Semin Immunopathol 2003; 24:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/22\">",
"      Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 2004; 66:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/23\">",
"      Erlich JH, Apostolopoulos J, Wun TC, et al. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 1996; 98:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/24\">",
"      Cunningham MA, Ono T, Hewitson TD, et al. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int 1999; 55:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/25\">",
"      Cunningham MA, Rondeau E, Chen X, et al. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000; 191:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/26\">",
"      Kitching AR, Holdsworth SR, Ploplis VA, et al. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 1997; 185:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/27\">",
"      Kitching AR, Kong YZ, Huang XR, et al. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2003; 14:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/28\">",
"      Rondeau E, Mougenot B, Lacave R, et al. Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 1990; 33:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/29\">",
"      Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 1996; 7:2271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/30\">",
"      Moussa L, Apostolopoulos J, Davenport P, et al. Protease-activated receptor-2 augments experimental crescentic glomerulonephritis. Am J Pathol 2007; 171:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/31\">",
"      Tipping PG, Holdsworth SR. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol 1986; 124:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/32\">",
"      Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol 1997; 110:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/33\">",
"      Li HL, Hancock WW, Dowling JP, Atkins RC. Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 1991; 39:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/34\">",
"      Boucher A, Droz D, Adafer E, No&euml;l LH. Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 1987; 56:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/35\">",
"      Lloyd CM, Dorf ME, Proudfoot A, et al. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 1997; 62:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/36\">",
"      Lan HY, Yu XQ, Yang N, et al. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 1998; 53:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/37\">",
"      Wada T, Furuichi K, Segawa-Takaeda C, et al. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/38\">",
"      Hudkins KL, Giachelli CM, Eitner F, et al. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int 2000; 57:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/39\">",
"      Segerer S, Cui Y, Hudkins KL, et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/40\">",
"      Nishikawa K, Guo YJ, Miyasaka M, et al. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 1993; 177:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/41\">",
"      Adler S, Brady HR. Cell adhesion molecules and the glomerulopathies. Am J Med 1999; 107:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/42\">",
"      Timoshanko JR, Kitching AR, Semple TJ, et al. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J Am Soc Nephrol 2005; 16:2646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/43\">",
"      Lan HY, Nikolic-Paterson DJ, Mu W, et al. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 1995; 47:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/44\">",
"      Khan SB, Cook HT, Bhangal G, et al. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 2005; 67:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/45\">",
"      Lan HY, Yang N, Metz C, et al. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 1997; 3:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/46\">",
"      Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 2003; 14:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/47\">",
"      Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/48\">",
"      Song CY, Kim BC, Hong HK, Lee HS. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis. Kidney Int 2007; 71:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/49\">",
"      Goumenos DS, Kalliakmani P, Tsakas S, et al. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis. BMC Nephrol 2005; 6:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/50\">",
"      Isaka Y, Akagi Y, Ando Y, et al. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1999; 55:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/51\">",
"      Isaka Y, Nakamura H, Mizui M, et al. DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 2004; 66:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/52\">",
"      Border WA, Ruoslahti E. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. Cell Differ Dev 1990; 32:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/53\">",
"      Chavele KM, Martinez-Pomares L, Domin J, et al. Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Invest 2010; 120:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/54\">",
"      Sanders JS, van Goor H, Hanemaaijer R, et al. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004; 19:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/55\">",
"      Nakopoulou L, Lazaris AC, Boletis I, et al. The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis. Nephrol Dial Transplant 2007; 22:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/56\">",
"      Lelongt B, Bengatta S, Delauche M, et al. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med 2001; 193:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/57\">",
"      Cunningham MA, Huang XR, Dowling JP, et al. Prominence of cell-mediated immunity effectors in \"pauci-immune\" glomerulonephritis. J Am Soc Nephrol 1999; 10:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/58\">",
"      Kitching AR, Turner AL, Wilson GR, et al. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J Am Soc Nephrol 2005; 16:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/59\">",
"      Odobasic D, Kitching AR, Semple TJ, et al. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. J Am Soc Nephrol 2005; 16:2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/60\">",
"      Timoshanko JR, Kitching AR, Semple TJ, et al. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2006; 17:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/61\">",
"      Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997; 185:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/62\">",
"      Hyodo T, Oda T, Kikuchi Y, et al. Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol 2010; 299:F1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/63\">",
"      Nitta K, Horita S, Honda K, et al. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis. Virchows Arch 1999; 435:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/64\">",
"      Smeets B, Uhlig S, Fuss A, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 2009; 20:2604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/65\">",
"      Shirato I, Asanuma K, Takeda Y, et al. Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000; 11:2381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/66\">",
"      Barisoni L, Nelson PJ. Collapsing glomerulopathy: an inflammatory podocytopathy? Curr Opin Nephrol Hypertens 2007; 16:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/67\">",
"      Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009; 20:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/68\">",
"      Le Hir M, Keller C, Eschmann V, et al. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2001; 12:2060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/69\">",
"      Moeller MJ, Soofi A, Hartmann I, et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004; 15:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/70\">",
"      Bari&eacute;ty J, Bruneval P, Meyrier A, et al. Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int 2005; 68:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/71\">",
"      Bariety J, Hill GS, Mandet C, et al. Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant 2003; 18:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/72\">",
"      Thorner PS, Ho M, Eremina V, et al. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 2008; 19:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/73\">",
"      Ding M, Cui S, Li C, et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006; 12:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/74\">",
"      Boll&eacute;e G, Flamant M, Schordan S, et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; 17:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/75\">",
"      Flamant M, Boll&eacute;e G, H&eacute;nique C, Tharaux PL. Epidermal growth factor: a new therapeutic target in glomerular disease. Nephrol Dial Transplant 2012; 27:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/76\">",
"      Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009; 20:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/77\">",
"      Smeets B, Angelotti ML, Rizzo P, et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009; 20:2593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/78\">",
"      Ng YY, Fan JM, Mu W, et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999; 14:2860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/79\">",
"      Bennett WM, Kincaid-Smith P. Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int 1983; 23:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/80\">",
"      Praga M, Gutierrez-Millet V, Navas JJ, et al. Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 1985; 28:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/81\">",
"      Fogazzi GB, Imbasciati E, Moroni G, et al. Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant 1995; 10:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/82\">",
"      Kriz W, H&auml;hnel B, Hosser H, et al. Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. J Am Soc Nephrol 2003; 14:1904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43448/abstract/83\">",
"      Chevalier RL, Forbes MS. Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 2008; 19:197.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3069 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43448=[""].join("\n");
var outline_f42_27_43448=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10381717\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIATING EVENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H540827538\">",
"      FORMATION AND COMPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Coagulation proteins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Tissue factor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Tissue factor pathway inhibitor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H181098138\">",
"      - Thrombin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Plasminogen/plasmin system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Macrophages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      T cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glomerular parietal epithelial cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Glomerular visceral epithelial cells (podocytes)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7074941\">",
"      Renal progenitor cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17198248\">",
"      Interstitial fibroblasts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      COURSE OF CRESCENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10381717\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1045895527\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3069\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3069|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/50/20259\" title=\"figure 1\">",
"      Glomerular structure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3069|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/27/21945\" title=\"picture 1\">",
"      RPGN Light High",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/55/22393\" title=\"picture 2\">",
"      RPGN Light High II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/56/25480\" title=\"picture 3\">",
"      RPGN EM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/11/17599\" title=\"picture 4\">",
"      RPGN IF Fibrin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18921?source=related_link\">",
"      Mechanisms of immune injury of the glomerulus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18231?source=related_link\">",
"      Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40261?source=related_link\">",
"      Pathogenesis of tissue injury in glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=related_link\">",
"      T helper subsets: Differentiation and role in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/7/42106?source=related_link\">",
"      Treatment and prognosis of IgA nephropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_27_43449="Strategies to control the rate of high order multiple gestation";
var content_f42_27_43449=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Strategies to control the rate of high order multiple gestation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Wendy Kuohung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Elizabeth S Ginsburg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Catherine Racowsky, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/27/43449/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/27/43449/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of multiple gestation has risen significantly over several decades, primarily due to increased use of fertility drugs for ovulation induction, superovulation, and assisted reproductive technologies (ART), such as in vitro fertilization (IVF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In 1960, before the commercial availability of drugs for treatment of infertility, there were approximately 4.3 million births in the United States, with 1198 triplets and 46 quadruplets or more [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3\">",
"     3",
"    </a>",
"    ]. In 2010, the total number of births was slightly lower (about 4 million), but there were 5153 triplet, 313 quadruplet, and 37 quintuplet births; these numbers do not include those high order multiple gestations (ie, pregnancies with at least three fetuses) reduced naturally or iatrogenically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/4\">",
"     4",
"    </a>",
"    ]. Approximately 20 percent of high order multiple births are naturally conceived, 39 to 67 percent are related to ovulation",
"    <span class=\"nowrap\">",
"     induction/superovulation,",
"    </span>",
"    and 13 to 44 percent are associated with ART [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among women undergoing IVF with fresh nondonor embryos in 2009, the rates of singleton, twin, and triplets-or-more pregnancies were 61.7, 28.5, and 3.1 percent, respectively (6.7 percent undetermined at early miscarriage) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/6\">",
"     6",
"    </a>",
"    ]. By comparison, in 2010, 3.4 percent of all live births in the United States were multiple gestations (twins 3.3 percent, triplets or more 0.14 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of insurance coverage for ART in most of the United States, as well as competition among ART programs, has generated pressure to achieve success in a minimal number of cycles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. One strategy has been to increase the number of embryos transferred per IVF procedure. An analysis of 1998 Society of Assisted Reproductive Technology (SART) data demonstrated that providers in states without insurance coverage for IVF transferred more embryos per cycle, had a higher percentage of cycles resulting in pregnancy, and encountered an increased frequency of high order gestations compared to providers in states with IVF insurance coverage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infertility patients often consider the birth of twins acceptable, or even desirable, since it may result in a completed family after (sometimes) years of infertility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. Nevertheless, there is a need for effective methods to reduce the frequency of multiple gestation, particularly high order pregnancies. Multiple gestations are at significantly increased risk of fetal, neonatal, and maternal complications, as well as complete pregnancy loss, when compared to singleton pregnancies (",
"    <a class=\"graphic graphic_table graphicRef67721 \" href=\"mobipreview.htm?8/20/8524\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"     5",
"    </a>",
"    ]. As an example, in one review, the risk of delivery &lt;32 weeks of gestation for singleton, twin, triplet, and quadruplet pregnancies was 2, 8, 26, and &gt;95 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"     5",
"    </a>",
"    ]. In another study that compared twin pregnancy outcome with outcome of two successive singleton pregnancies delivered by the same mother, adverse pregnancy and neonatal outcomes were significantly increased for IVF twins compared with two successive IVF singleton pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The economic and psychological impact on families raising children of a multiple gestation is also important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. In one study, for example, 22 percent of mothers of multiples had Parenting Stress Index scores indicating severe parenting stress, compared with 5 percent of mothers of IVF singletons and 9 percent of mothers of naturally conceived singletons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/17\">",
"     17",
"    </a>",
"    ]. Another study found that each additional child more than tripled the odds of not being able to meet basic material needs and doubled the odds of a lowered quality of life for the family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27594?source=see_link&amp;anchor=H40#H40\">",
"     \"Neonatal outcome, complications, and management of multiple births\", section on 'Impact on family'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ideal ART outcome is the delivery of a single, healthy child. Some progress toward this goal has been made as a result of refinements in embryo evaluation and patient selection. High order pregnancy rates have fallen from a peak of 0.19 percent of all births in 1997 to 0.15 percent of all births in 2008, despite an increase in the number of procedures, but the twin birth has increased from 2.8 to 3.4 percent of all births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"     5",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Several strategies attempting to control the frequency of high order multiples have been implemented, sometimes on a national scale. The overriding aim of these strategies is to transfer fewer embryos of higher quality to maximize the pregnancy rate and minimize the risk of high order multiple gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LIMITING THE MULTIPLE GESTATION RISK OF ART",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restricting the number of embryos transferred during IVF increases the proportion of singleton births. National legislation in several European countries restricting the number of embryos transferred has proven to be effective in reducing the high order pregnancy rate, although there has been a trade-off in terms of lower delivery rates (",
"    <a class=\"graphic graphic_table graphicRef71188 \" href=\"mobipreview.htm?15/61/16347\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 1998, the American Society for Reproductive Medicine (ASRM) issued practice guidelines on the number of embryos to transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/21\">",
"     21",
"    </a>",
"    ] and periodically revised the guidelines, most recently in 2013 (",
"    <a class=\"graphic graphic_table graphicRef56555 \" href=\"mobipreview.htm?6/39/6780\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/22\">",
"     22",
"    </a>",
"    ]. These guidelines suggest limiting the number of embryos transferred based upon maternal age and embryo quality, as assessed by the availability of embryos for cryopreservation.",
"   </p>",
"   <p>",
"    The ASRM guidelines have had a significant impact on practice patterns and outcomes, resulting in a shift toward transfer of fewer embryos [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/23\">",
"     23",
"    </a>",
"    ]. The percentage of ART cycles in the US with transfer of one, two, three, or four or more embryos in 1996 versus 2009 was: one embryo 6 versus 13.5 percent, two embryos 10 versus 51.5 percent, three embryos 23 versus 23.4 percent, and four embryos 62 versus 7.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/6\">",
"     6",
"    </a>",
"    ]. There are no legal regulations in the United States limiting the numbers of embryos transferred.",
"   </p>",
"   <p>",
"    Although the rate of IVF pregnancies with twins has not changed significantly over time, the rate of triplets and higher order multiple gestations has decreased by approximately 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. These data do not include rates of multifetal pregnancy reduction; thus, the contribution of pregnancy reduction to this decrease in high order multiple pregnancy is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94578635\">",
"    <span class=\"h2\">",
"     Factors affecting multiple gestation risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimum number of embryos to transfer depends on a number of factors, which are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Maternal age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies consistently demonstrate that live birth rates after ART decrease with advancing age. The importance of maternal age on the risk of multiple gestation after embryo transfer is illustrated by 2006 ART surveillance data reporting multiple birth rates after transfer of three or two embryos in women of various age groups (",
"    <a class=\"graphic graphic_table graphicRef59373 \" href=\"mobipreview.htm?26/54/27499\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/26\">",
"     26",
"    </a>",
"    ]. Live birth rates and twin rates were comparable for all age groups whether three or two embryos were transferred, but transfer of two embryos resulted in substantial reductions in the incidence of high order multiple births, especially among younger women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Embryo quality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to select only the highest quality embryos would allow transfer of fewer of them while achieving acceptable birth rates. Embryo quality is assessed in a number of ways, with morphological evaluation remaining the first-line method for assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/27\">",
"     27",
"    </a>",
"    ]. However, new approaches using growth factors and targeted biomarkers, such as amino acid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/28\">",
"     28",
"    </a>",
"    ], metabolomic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/29\">",
"     29",
"    </a>",
"    ], proteomic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/30\">",
"     30",
"    </a>",
"    ], and genomic assays, may improve our ability to assess embryos in the future [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h4\">",
"     Number of eggs fertilized",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of embryo quality was demonstrated in a study that found higher pregnancy rates when more than four eggs fertilized and two embryos were transferred than when only two eggs fertilized and two embryos were transferred [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/32\">",
"     32",
"    </a>",
"    ]. Presumably fertilization of four eggs provided a higher chance of selecting quality embryos for transfer. In all maternal age groups up to age 40 years, when four eggs fertilized, the transfer of two, rather than three, embryos reduced the risk of high order birth without decreasing the chance of live birth.",
"   </p>",
"   <p>",
"    Similarly, a CDC study of 35,554 IVF transfers showed that for all age groups, increased availability of embryo choice (indicated by the cryopreservation of at least one embryo) resulted in higher live birth rates despite fewer transferred embryos [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h4\">",
"     Morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morphological criteria associated with improved embryo quality are used to identify developmentally competent embryos for transfer. The human zygote should undergo the first cleavage division by 30 hours post-insemination, the second cleavage division by approximately 44 hours, and the third cleavage division to the 8-cell stage by 68 to 72 hours (",
"    <a class=\"graphic graphic_figure graphicRef55217 \" href=\"mobipreview.htm?35/4/35904\">",
"     figure 1",
"    </a>",
"    ). Embryos developing more slowly than described in this timeline are less likely to implant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Determining a cumulative embryo score encompassing the three characteristics of cell number, fragmentation, and embryo symmetry can help to select the most viable embryos, thereby maintaining implantation rates while reducing the need to transfer many embryos and the concomitant risk of multiple gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/27,35\">",
"     27,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional morphologic criteria that have been developed for assessing embryo quality include fragment distribution among the blastomeres, morphology of the first polar body, pronuclear orientation, pronuclear morphology, time of initial cleavage, and mononucleate blastomeres [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/36-47\">",
"     36-47",
"    </a>",
"    ]. Independently, all of these characteristics have been found to enhance implantation and pregnancy rates when used to select embryos for transfer.",
"   </p>",
"   <p>",
"    While numerous studies have evaluated the utility of multi-day embryo assessment for selection of embryos for day 3 transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/48\">",
"     48",
"    </a>",
"    ], one study showed that day 2 or day 3 evaluations alone are sufficient for morphological assessment of cleavage stage embryos [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/49\">",
"     49",
"    </a>",
"    ]. Nevertheless, an embryo grading system incorporating characteristics from the pronucleate to the blastocyst stage may eventually be employed to select developmentally superior embryos for transfer on days 5 or 6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Preimplantation genetic screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preimplantation genetic screening (PGS) has been used to test for aneuploidy, but does not improve live birth rates. The rationale for this procedure is that the ability to transfer chromosomally normal embryos should increase the overall success rate of ART. However, PGS is invasive and involves removing one or more cells from the embryo for testing. Injury to the embryo during biopsy and indeterminate genetic results may contribute to embryo loss. Data from randomized trials and prospective controlled studies have shown that PGS does not improve live birth rates in women of any age or in women with unexplained recurrent miscarriage, and may in fact lower them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/51\">",
"     51",
"    </a>",
"    ]; there are also no data that it improves IVF success rates in women with repeated implantation failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/56/23431?source=see_link\">",
"     \"Preimplantation genetic diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Assessment of noninvasive biomarkers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methods to determine embryo competence through noninvasive techniques, including the assay of spent culture medium, are an active area of investigation. Some of these methods are illustrated below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In pilot studies, levels of interleukin-1 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/53\">",
"       53",
"      </a>",
"      ], interleukin-10 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/54\">",
"       54",
"      </a>",
"      ], and embryonic platelet-activating factor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/55\">",
"       55",
"      </a>",
"      ] in embryo-conditioned media samples predicted implantation.",
"     </li>",
"     <li>",
"      Amino acid profiling by high performance liquid chromatography of single embryo media samples found different amino acid flux patterns in day",
"      <span class=\"nowrap\">",
"       2/3",
"      </span>",
"      embryos that later reached blastocyst stage compared to those that arrested in development [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/56\">",
"       56",
"      </a>",
"      ]. Also, day 4 uptake of pyruvate and glucose by embryos that went on to form blastocysts was higher than in those that arrested [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nontransferred sibling embryos from patients who became pregnant demonstrated significantly higher expression of human leukocyte antigen G (HLA-G) than those from patients who did not conceive after IVF [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/58\">",
"       58",
"      </a>",
"      ]. Further evidence for the importance of HLA-G expression was demonstrated in a study of 285 embryo culture media samples from 101 patients undergoing IVF that showed that implantation occurred only in patients with soluble HLA-G antigen in culture supernatants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The self-referencing electrode technique, which monitors oxygen consumption and other molecule and ion gradients surrounding embryos, has been used to show changes in oxygen consumption that accompany important physiological events such as development, response to medium metabolites, or cell death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/60,61\">",
"       60,61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Metabolomic and proteomic profiling that screen spent culture media for changes in metabolite and protein content has been applied to identify profiles unique to embryos that have implanted [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/30,62,63\">",
"       30,62,63",
"      </a>",
"      ]. However, no prospective randomized trials have been performed to prove that these approaches are superior to morphological assessment for embryo selection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Day of transfer",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2009, in the US, the frequency of embryo transfer by day of transfer was: day 1 (0.1 percent), day 2 (4.9 percent), day 3 (54.6 percent), day 4 (2.5 percent), day 5 (35.9 percent), day 6 (2.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Day 2 or 3 (cleavage stage)",
"    </span>",
"    &nbsp;&mdash;&nbsp;As improvements in IVF culture media in the late 1980s permitted longer duration of embryo culture, it was noted that not all early cleavage stage embryos continued to develop normally. The additional 24 hours in culture from day 2 to day 3 allowed identification of embryos that arrested at the 4-cell stage (",
"    <a class=\"graphic graphic_figure graphicRef55217 \" href=\"mobipreview.htm?35/4/35904\">",
"     figure 1",
"    </a>",
"    ). A general movement toward transferring human embryos on day 3 rather than on day 2 resulted in enhanced success rates with transfer of fewer embryos and, ultimately, fewer multiple gestations. Initially, however, there was a spike in high order multiple gestation after day 3 transfer was implemented because embryo transfer guidelines had not been revised to transfer fewer embryos to correct for better success rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additionally, it should be noted that some studies have reported that poor prognosis patients may benefit from transferring embryos on day 2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Day 5 (blastocyst stage)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metabolic requirements of the human embryo demand changes in culture as the genome switches on at the 8-cell stage. The ability to serve these changing metabolic needs has permitted culture to day 5 and enabled identification of the most developmentally superior blastocysts (",
"    <a class=\"graphic graphic_figure graphicRef55217 \" href=\"mobipreview.htm?35/4/35904\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/66-68\">",
"     66-68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are both advantages and disadvantages to blastocyst culture and transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/69\">",
"     69",
"    </a>",
"    ]. Transfer on day 5 is more natural as it takes about four days for the naturally fertilized egg (zygote) to travel through the fallopian tube and reach the uterine cavity. Only one or two blastocysts need to be transferred to maintain overall success rates, while decreasing the high order multiple pregnancy rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/68,70-74\">",
"     68,70-74",
"    </a>",
"    ]. If only one or two blastocysts are transferred, triplet pregnancy should not occur unless one of the blastocysts divides to form monozygotic twins. In fact, however, the frequency of monozygotic twinning appears to be higher with blastocyst transfer than with cleavage stage transfer (OR 3.04, 95% CI 1.54-6.01; 1.64 versus 0.41 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/75\">",
"     75",
"    </a>",
"    ]. Some studies show up to 5 percent monochorionic twinning rates, with a further increase in risk if the embryos were formed following ICSI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/76\">",
"     76",
"    </a>",
"    ]. Additional concerns about the use of blastocysts include the possibilities of an altered sex ratio of births favoring males (OR 1.29, 95% CI 1.1-1.5) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/75\">",
"     75",
"    </a>",
"    ], epigenetic effects on the embryo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/75\">",
"     75",
"    </a>",
"    ], and increased risk of preterm delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. However, for ongoing pregnancies, most pregnancy outcomes are similar for Day 5 versus Day 3 transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other drawbacks of blastocyst transfer include the potential for loss in extended culture of embryos that may have successfully implanted if transferred on day 3, and the potentially poorer long-term survival of embryos cryopreserved on day 5. This was illustrated in a meta-analysis of randomized trials comparing blastocyst and cleavage stage transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/80\">",
"     80",
"    </a>",
"    ]. The live birth rate per randomized patient was significantly higher in patients who had a blastocyst stage transfer (OR 1.39, 95% CI 1.10-1.76), and the multiple pregnancy rate was similar for both groups when an equal number of embryos was transferred, but the blastocyst stage group also had a higher cycle cancellation rate (OR 2.21, 95% CI 1.47-3.32) and lower cryopreservation rate (OR 0.28, 95% CI 0.14-0.55) compared with the cleavage stage group.",
"   </p>",
"   <p>",
"    Patients with no 8-cell embryos on day 3 have a significantly lower chance of conceiving after a day 5 transfer than after a day 3 transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/81\">",
"     81",
"    </a>",
"    ]. When cumulative day 3 pregnancy rates include the results of cryopreserved embryo cycles, there may be no advantage of day 5 transfer per controlled ovarian hyperstimulation in patients with good prognosis (defined as either first IVF cycle plus good embryo quality plus sufficient embryos for cryopreservation or previous IVF success). However, survival of cryopreserved blastocysts varies among centers, and can be quite good. In addition, if only patients with a good prognosis or donor egg cycles are selected, some retrospective studies (but not all) reported that prolonging embryo culture to day 5 improved embryo selection and implantation rates and achieved a significant decrease in high order gestations by reducing the number of embryos transferred, without compromising the pregnancy rates from the fresh transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/71,81-87\">",
"     71,81-87",
"    </a>",
"    ]. One could argue that there is no reason to transfer more than two embryos in these good prognosis patients, per SART guidelines. One [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/88\">",
"     88",
"    </a>",
"    ] of nine randomized trials comparing day 3 versus day 5 transfer reported similar findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/88-96\">",
"     88-96",
"    </a>",
"    ] and none of these trials showed an increase in high order multiple gestation in patients undergoing day 5 embryo transfer.",
"   </p>",
"   <p>",
"    It may be prudent to restrict day 5 embryo transfer to younger patients (usually under age 40) with a number of good quality embryos (patient age cutoffs and the minimum number of good quality embryos will vary from center to center). One or two blastocysts are transferred based on the patient's age, embryo quality, and cycle history. This approach attempts to reduce the risk of high order multiple pregnancy without increasing cycle cancellation rates or decreasing implantation rates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Single embryo transfer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most effective method of avoiding high order multiple pregnancy is single embryo transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5,97\">",
"     5,97",
"    </a>",
"    ]. Elective single embryo transfer (eSET) is defined as transfer of one good quality embryo in cases in which at least two good quality embryos are available. Practice committees of the Society of Assisted Reproductive Technology and the American Society for Reproductive Medicine suggest that eSET is most appropriate for women with a good prognosis for conception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/97\">",
"     97",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &lt;35 years",
"     </li>",
"     <li>",
"      More than one high quality embryo for transfer",
"     </li>",
"     <li>",
"      First or second IVF treatment cycle",
"     </li>",
"     <li>",
"      Recipients of embryos from donated eggs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evidence for the efficacy of this approach was provided in a meta-analysis of six randomized trials of single versus double embryo transfer (DET) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/98\">",
"     98",
"    </a>",
"    ]. This meta-analysis did not include blastocyst transfer cycles due to (1) the small number of patients undergoing these transfers in published studies, and (2) higher implantation rates and monozygotic twinning rates with blastocyst transfer as compared to cleavage stage embryos transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/99\">",
"     99",
"    </a>",
"    ]. This comparative analysis of eSET versus DET showed that in women younger than 36 years, eSET of cleavage stage embryos decreased the likelihood of live birth by 38 percent, but decreased the risk of multiple birth by 94 percent. eSET also reduced the risk of preterm birth. The authors postulated that offering women additional eSET cycles would help to achieve a satisfactory live birth rate per patient without increasing the rate of multiple births.",
"   </p>",
"   <p>",
"    Subsequently, a prospective nonrandomized study in which select patients were offered eSET and either accepted eSET (53 women) or opted for DET (98 women) showed no difference in cumulative delivery rate (54.7 percent with eSET and 49.0 percent with DET) and a 10-fold lower rate in twin deliveries in the eSET group (3.5 versus 37.5 percent, P&lt;0.05) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/100\">",
"     100",
"    </a>",
"    ]. Criteria for offering eSET included age &lt;36 years with adequate ovarian reserve on testing, a first or second IVF or ICSI attempt with ejaculated sperm, and having a least four mature oocytes and two fertilized top quality embryos. Neonatal outcomes in the twins were poorer than in the singleton pregnancies. These data suggest that single embryo transfer is superior to double embryo transfer when the number of deliveries with at least one live born child, incremental cost-effectiveness ratio, and maternal and pediatric complications are taken into account [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/101,102\">",
"     101,102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a single embryo is transferred, the pregnancy rate appears to be better with transfer at the blastocyst rather than the cleavage stage. In a randomized trial, blastocyst versus cleavage stage transfer was associated with significantly higher pregnancy rates, 32 and 21.6 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/103\">",
"     103",
"    </a>",
"    ]. Two multiple gestations occurred, both among cleavage stage transfers. All of the women in this trial were under 36 years of age; therefore, these results may not apply to older women, who comprise the majority of ART patients. It is also important to understand that when embryo quality is suboptimal at the cleavage stage, further development to the blastocyst stage is compromised. Blastocyst transfer is unwise in such cases and may actually result in no viable blastocysts to transfer; hence, in these cases, a cleavage stage transfer should be performed.",
"   </p>",
"   <p>",
"    Utilization of eSET will likely increase as methods of predicting embryo viability improve and pressure to reduce high order pregnancy mounts. A randomized trial found that well-informed and supported patients were more likely to choose eSET than patients receiving usual care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/104\">",
"     104",
"    </a>",
"    ]. For women under 35 years of age for whom eSET is planned and who meet their center's criteria for day 5 embryo transfer, we suggest transferring a single day 5 blastocyst or high quality cleavage stage embryo.",
"   </p>",
"   <p>",
"    Although eSET is associated with a higher rate of singleton pregnancy, the outcomes of these singleton pregnancies are less optimal than those of spontaneously conceived singleton pregnancies. In a systematic review of randomized trials and cohort studies that compared the outcome of eSET conceived singletons to spontaneously conceived singletons, eSET pregnancies were at higher risk of preterm birth (RR 2.13, 95% CI 1.26-3.61), placenta previa (RR 6.02, 95% CI 2.79-13.01) and ectopic pregnancy (RR 6.40, 95% CI 4.38-9.35) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/105\">",
"     105",
"    </a>",
"    ]. This finding may be due to factors associated with infertility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the process of ART. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/6/2154?source=see_link&amp;anchor=H9#H9\">",
"     \"Pregnancy outcome after assisted reproductive technology\", section on 'Preterm birth, LBW, and SGA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     LIMITING THE MULTIPLE GESTATION RISK OF OVULATION INDUCTION AND SUPEROVULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is estimated that 39 to 67 percent of high order multiple births are related to ovulation induction without IVF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"     5",
"    </a>",
"    ], and ovulation induction accounts for essentially 100 percent of multiple pregnancies with six or more fetuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/106\">",
"     106",
"    </a>",
"    ]. Thus, ovulation induction and superovulation account for the largest proportion of high order multiple gestations. The contribution of ovulation induction to high order multiple births is rising, while the number of these births from IVF is falling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of large follicles present on the day of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/60/26564?source=see_link\">",
"     human chorionic gonadotropin",
"    </a>",
"    (hCG) administration is a key factor in determining the risk of multiple gestation in superovulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/107\">",
"     107",
"    </a>",
"    ]. In one series of 4062 cycles, the incidence of high order multiple pregnancy by number of follicles of diameter &ge;10 mm was: 5 to 6 percent with four to six follicles, 14 percent with seven to eight follicles, and 19 percent with nine or more follicles present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/108\">",
"     108",
"    </a>",
"    ]. Factors associated with the highest risk of high order multiple pregnancies included age &lt;32 years, having seven or more follicles of diameter &ge;10 mm, and an estradiol concentration &ge;1000",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (note: this value is assay-dependent). Interestingly, this study also showed that high order multiple pregnancy did not occur after the first cycle unless there were more than seven follicles, and did not occur after the second cycle regardless of follicle number, which suggests that gonadotropin dosing may be safely increased after the first cycle with close monitoring of follicle development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the first cycle, however, the dose of gonadotropin and length of stimulation are highly important factors. For example, high order multiples have been reported in 6 to 9 percent of cycles with FSH or hMG dose &ge;150 IU, but in &le;1 percent of cycles with doses of 37.5 to 75 IU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3\">",
"     3",
"    </a>",
"    ]. Similarly, the frequency of high order multiples fell when the duration of stimulation was lowered from &ge;12 days to less than 9 days.",
"   </p>",
"   <p>",
"    Strategies to reduce the high order multiple gestation rate from ovulation induction include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3,5,109-111\">",
"     3,5,109-111",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Begin with medication regimens associated with a low incidence of multiple follicles, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate, aromatase inhibitors, and pulsatile GnRH (where available), followed by the lowest effective gonadotropin dose [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Closely monitor follicle development with a strict cycle cancellation policy for patients with an excessive number of mature follicles (eg, greater than 3 follicles &ge;15 mm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/112\">",
"       112",
"      </a>",
"      ] or &ge;16 mm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/113\">",
"       113",
"      </a>",
"      ]).",
"     </li>",
"     <li>",
"      Alternatives to cycle cancellation include aspiration of supernumerary follicles before hCG administration or conversion to IVF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors of one analysis estimated that, depending on the strategy used, 5 to 20 percent of cycles would be canceled, but high order pregnancy rates would be less than 2 percent and pregnancy rates would average 10 to 20 percent per cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3\">",
"     3",
"    </a>",
"    ]. Pregnancy rates per patient would not be reduced if low gonadotropin doses were continued for four to six cycles. As the majority of patients are paying out of pocket for treatment, this might well be a difficult policy to implement.",
"   </p>",
"   <p>",
"    These issues are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MULTIFETAL PREGNANCY REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective analysis of ultrasound and birth information on 709 multiple and 5962 singleton pregnancies conceived at a private infertility clinic observed spontaneous reduction of one or more gestational sacs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    embryos in the first trimester in 36 percent of twin, 53 percent of triplet, and 65 percent of quadruplet pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/27/43449/abstract/114\">",
"     114",
"    </a>",
"    ]. For those that do not reduce spontaneously, iatrogenic fetal reduction may be used to lower the risks associated with multiple gestation. However, pregnancy reduction may not be an acceptable option for some patients. The procedure is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/9/39065?source=see_link\">",
"     \"Multifetal pregnancy reduction and selective termination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of twin and high order multiple gestations (ie, triplets or more) has risen over the past few decades, mainly due to increased use of fertility drugs for ovulation induction, superovulation, and assisted reproductive technology (ART). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ideal ART outcome is the delivery of a single, healthy child. Progress toward this goal has been made as a result of improvements in embryo evaluation and patient selection, including limiting the number of embryos transferred based on maternal age and embryo",
"      <span class=\"nowrap\">",
"       quality/availability",
"      </span>",
"      for cryopreservation. However, additional research is needed to develop more accurate methods of embryo selection. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Limiting the multiple gestation risk of ART'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most effective method of avoiding high order multiple pregnancy is single embryo transfer, when appropriate. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Single embryo transfer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For woman under 35 years of age for whom single embryo transfer is planned and who meet their center's criteria for day 5 embryo transfer, we suggest transferring a single day 5 blastocyst rather than cleavage stage transfer, provided patients are counseled that there is an increased risk of monozygotic twinning and an increased likelihood of having a male with blastocyst transfer (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Day of transfer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For programs who do not perform blastocyst transfers, we suggest single rather than double cleavage stage embryo transfer for women under age 35 who have other good quality embryos available for transfer (",
"      <a class=\"graphic graphic_table graphicRef56555 \" href=\"mobipreview.htm?6/39/6780\">",
"       table 3",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Day of transfer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For all other women, maternal age and embryo",
"      <span class=\"nowrap\">",
"       quality/availability",
"      </span>",
"      for cryopreservation need to be taken into account in determining the optimal number of embryos to transfer (",
"      <a class=\"graphic graphic_table graphicRef56555 \" href=\"mobipreview.htm?6/39/6780\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Limiting the multiple gestation risk of ART'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women undergoing ovulation induction without in vitro fertilization (IVF), we suggest beginning with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate, aromatase inhibitors, or pulsatile GnRH (where available) as appropriate, rather than gonadotropins in order to reduce the risk of high order multiple gestation. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Limiting the multiple gestation risk of ovulation induction and superovulation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/10/13482?source=see_link\">",
"       \"Overview of ovulation induction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In women with an excessive number of mature follicles, we suggest conversion to IVF or cycle cancellation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Limiting the multiple gestation risk of ovulation induction and superovulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fetal reduction is an option for reduction of high order multiple gestations. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Multifetal pregnancy reduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/1\">",
"      Luke B. The changing pattern of multiple births in the United States: maternal and infant characteristics, 1973 and 1990. Obstet Gynecol 1994; 84:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/2\">",
"      Rebar RW, DeCherney AH. Assisted reproductive technology in the United States. N Engl J Med 2004; 350:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/3\">",
"      Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertil Steril 2009; 91:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/4\">",
"      Births: Final data for 2010. Natl Vital Stat Rep 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/5\">",
"      Practice Committee of American Society for Reproductive Medicine. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertil Steril 2012; 97:825.",
"     </a>",
"    </li>",
"    <li>",
"     2009 SART file://www.cdc.gov/ART/ART2009 (Accessed on February 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/7\">",
"      Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med 2002; 347:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/8\">",
"      Reynolds MA, Schieve LA, Jeng G, Peterson HB. Does insurance coverage decrease the risk for multiple births associated with assisted reproductive technology? Fertil Steril 2003; 80:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/9\">",
"      Ryan GL, Zhang SH, Dokras A, et al. The desire of infertile patients for multiple births. Fertil Steril 2004; 81:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/10\">",
"      Gleicher N, Campbell DP, Chan CL, et al. The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod 1995; 10:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/11\">",
"      Pinborg A, Loft A, Schmidt L, Andersen AN. Attitudes of IVF/ICSI-twin mothers towards twins and single embryo transfer. Hum Reprod 2003; 18:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/12\">",
"      Child TJ, Henderson AM, Tan SL. The desire for multiple pregnancy in male and female infertility patients. Hum Reprod 2004; 19:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/13\">",
"      Gleicher N, Barad D. Twin pregnancy, contrary to consensus, is a desirable outcome in infertility. Fertil Steril 2009; 91:2426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/14\">",
"      Sazonova A, K&auml;llen K, Thurin-Kjellberg A, et al. Neonatal and maternal outcomes comparing women undergoing two in&nbsp;vitro fertilization (IVF) singleton pregnancies and women undergoing one IVF twin pregnancy. Fertil Steril 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/15\">",
"      Multiple gestation pregnancy. The ESHRE Capri Workshop Group. Hum Reprod 2000; 15:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/16\">",
"      Thorpe K, Golding J, MacGillivray I, Greenwood R. Comparison of prevalence of depression in mothers of twins and mothers of singletons. BMJ 1991; 302:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/17\">",
"      Glazebrook C, Sheard C, Cox S, et al. Parenting stress in first-time mothers of twins and triplets conceived after in vitro fertilization. Fertil Steril 2004; 81:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/18\">",
"      Ellison MA, Hotamisligil S, Lee H, et al. Psychosocial risks associated with multiple births resulting from assisted reproduction. Fertil Steril 2005; 83:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/19\">",
"      Nygren KG, Andersen AN, European IVF-monitoring programme (EIM). Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. European Society of Human Reproduction and Embryology. Hum Reprod 2001; 16:2459.",
"     </a>",
"    </li>",
"    <li>",
"     CDC/SART Registry, 2001.",
"    </li>",
"    <li>",
"     American Society for Reproductive Medicine. Guidelines on Number of Embryos Transferred. American Society for Reproductive Medicine, Birmingham, Ala 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/22\">",
"      Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion. Fertil Steril 2013; 99:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/23\">",
"      Dickey RP. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred. Fertil Steril 2007; 88:1554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/24\">",
"      Jain T, Missmer SA, Hornstein MD. Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States. N Engl J Med 2004; 350:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/25\">",
"      Stern JE, Cedars MI, Jain T, et al. Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States. Fertil Steril 2007; 88:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/26\">",
"      Sunderam S, Chang J, Flowers L, et al. Assisted reproductive technology surveillance--United States, 2006. MMWR Surveill Summ 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/27\">",
"      Racowsky C, Vernon M, Mayer J, et al. Standardization of grading embryo morphology. Fertil Steril 2010; 94:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/28\">",
"      Brison DR, Houghton FD, Falconer D, et al. Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Hum Reprod 2004; 19:2319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/29\">",
"      Seli E, Vergouw CG, Morita H, et al. Noninvasive metabolomic profiling as an adjunct to morphology for noninvasive embryo assessment in women undergoing single embryo transfer. Fertil Steril 2010; 94:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/30\">",
"      Katz-Jaffe MG, Gardner DK, Schoolcraft WB. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril 2006; 85:101.",
"     </a>",
"    </li>",
"    <li>",
"     Scott, RT, Miller, KA, Olivares, R, et al. Microarray based 24 chromosome preimplantation genetic diagnosis (mPGD) is highly predictive of the reproductive potential of human embryos: a prospective blinded non-selection trial. Fertil Steril 2008; 90:S22.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/32\">",
"      Templeton A, Morris JK. Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N Engl J Med 1998; 339:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/33\">",
"      Erenus M, Zouves C, Rajamahendran P, et al. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization. Fertil Steril 1991; 56:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/34\">",
"      Testart J. Cleavage stage of human embryos two days after fertilization in vitro and their developmental ability after transfer into the uterus. Hum Reprod 1986; 1:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/35\">",
"      Shulman A, Ben-Nun I, Ghetler Y, et al. Relationship between embryo morphology and implantation rate after in vitro fertilization treatment in conception cycles. Fertil Steril 1993; 60:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/36\">",
"      Staessen C, Janssenswillen C, Van den Abbeel E, et al. Avoidance of triplet pregnancies by elective transfer of two good quality embryos. Hum Reprod 1993; 8:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/37\">",
"      Ziebe S, Petersen K, Lindenberg S, et al. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997; 12:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/38\">",
"      Giorgetti C, Terriou P, Auquier P, et al. Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers. Hum Reprod 1995; 10:2427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/39\">",
"      Alikani M, Cohen J, Tomkin G, et al. Human embryo fragmentation in vitro and its implications for pregnancy and implantation. Fertil Steril 1999; 71:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/40\">",
"      Ebner T, Yaman C, Moser M, et al. Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod 2000; 15:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/41\">",
"      Garello C, Baker H, Rai J, et al. Pronuclear orientation, polar body placement, and embryo quality after intracytoplasmic sperm injection and in-vitro fertilization: further evidence for polarity in human oocytes? Hum Reprod 1999; 14:2588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/42\">",
"      Ludwig M, Sch&ouml;pper B, Al-Hasani S, Diedrich K. Clinical use of a pronuclear stage score following intracytoplasmic sperm injection: impact on pregnancy rates under the conditions of the German embryo protection law. Hum Reprod 2000; 15:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/43\">",
"      Scott LA, Smith S. The successful use of pronuclear embryo transfers the day following oocyte retrieval. Hum Reprod 1998; 13:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/44\">",
"      Tesarik J, Greco E. The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod 1999; 14:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/45\">",
"      Sakkas D, Shoukir Y, Chardonnens D, et al. Early cleavage of human embryos to the two-cell stage after intracytoplasmic sperm injection as an indicator of embryo viability. Hum Reprod 1998; 13:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/46\">",
"      Shoukir Y, Campana A, Farley T, Sakkas D. Early cleavage of in-vitro fertilized human embryos to the 2-cell stage: a novel indicator of embryo quality and viability. Hum Reprod 1997; 12:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/47\">",
"      Jackson KV, Ginsburg ES, Hornstein MD, et al. Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles. Fertil Steril 1998; 70:60.",
"     </a>",
"    </li>",
"    <li>",
"     Skiadas, CC, Racowsky, C. Developmental rate, cumulative scoring, and embryonic viability. In: Human Preimplantation Embryo Selection, K, Elder, J Cohen (Eds), Informa Healthcare, UK Ltd.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/49\">",
"      Racowsky C, Ohno-Machado L, Kim J, Biggers JD. Is there an advantage in scoring early embryos on more than one day? Hum Reprod 2009; 24:2104.",
"     </a>",
"    </li>",
"    <li>",
"     Sakkas, D. Evaluation of embryo quality: A strategy for sequential analysis of embryo development with the aim of single embryo transfer. In: Laboratory and Clinical Perspectives, Gardner D, Weissman A, Howles C, Shoham Z (Eds), Martin Dunitz Press, London 2001 p. 223.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/51\">",
"      Harper J, Coonen E, De Rycke M, et al. What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee. Hum Reprod 2010; 25:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/52\">",
"      ACOG Committee Opinion No. 430: preimplantation genetic screening for aneuploidy. Obstet Gynecol 2009; 113:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/53\">",
"      Bara&ntilde;ao RI, Piazza A, Rumi LS, Polak de Fried E. Determination of IL-1 and IL-6 levels in human embryo culture-conditioned media. Am J Reprod Immunol 1997; 37:191.",
"     </a>",
"    </li>",
"    <li>",
"     Retzloff, MG, Combelles CMH, Bowman FP, Racowsky C, Schust DJ. Interleukin-10 levels in single embryo conditioned media samples help predict implantation [abstract]. American Society for Reproductive Medicine 59th Annual Meeting, San Antonio, Texas, October 11-15, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/55\">",
"      Roudebush WE, Wininger JD, Jones AE, et al. Embryonic platelet-activating factor: an indicator of embryo viability. Hum Reprod 2002; 17:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/56\">",
"      Houghton FD, Hawkhead JA, Humpherson PG, et al. Non-invasive amino acid turnover predicts human embryo developmental capacity. Hum Reprod 2002; 17:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/57\">",
"      Gardner DK, Lane M, Stevens J, Schoolcraft WB. Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential. Fertil Steril 2001; 76:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/58\">",
"      Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil Steril 1996; 65:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/59\">",
"      Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/60\">",
"      Trimarchi JR, Liu L, Porterfield DM, et al. Oxidative phosphorylation-dependent and -independent oxygen consumption by individual preimplantation mouse embryos. Biol Reprod 2000; 62:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/61\">",
"      Trimarchi JR, Liu L, Porterfield DM, et al. A non-invasive method for measuring preimplantation embryo physiology. Zygote 2000; 8:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/62\">",
"      Seli E, Sakkas D, Scott R, et al. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization. Fertil Steril 2007; 88:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/63\">",
"      Scott R, Seli E, Miller K, et al. Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study. Fertil Steril 2008; 90:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/64\">",
"      Racowsky C. High rates of embryonic loss, yet high incidence of multiple births in human ART: is this paradoxical? Theriogenology 2002; 57:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/65\">",
"      Shen S, Rosen MP, Dobson AT, et al. Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos. Fertil Steril 2006; 86:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/66\">",
"      Gardner DK, Lane M. Culture of viable human blastocysts in defined sequential serum-free media. Hum Reprod 1998; 13 Suppl 3:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/67\">",
"      Braude P, Bolton V, Moore S. Human gene expression first occurs between the four- and eight-cell stages of preimplantation development. Nature 1988; 332:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/68\">",
"      Wilson M, Hartke K, Kiehl M, et al. Transfer of blastocysts and morulae on day 5. Fertil Steril 2004; 82:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/69\">",
"      Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology. Blastocyst culture and transfer in clinical-assisted reproduction. Fertil Steril 2008; 90:S174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/70\">",
"      Marek D, Langley M, Gardner DK, et al. Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program. Fertil Steril 1999; 72:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/71\">",
"      Abdelmassih V, Balmaceda JP, Nagy ZP, et al. ICSI and day 5 embryo transfers: higher implantation rates and lower rate of multiple pregnancy with prolonged culture. Reprod Biomed Online 2001; 3:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/72\">",
"      Gardner DK, Surrey E, Minjarez D, et al. Single blastocyst transfer: a prospective randomized trial. Fertil Steril 2004; 81:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/73\">",
"      Criniti A, Thyer A, Chow G, et al. Elective single blastocyst transfer reduces twin rates without compromising pregnancy rates. Fertil Steril 2005; 84:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/74\">",
"      Henman M, Catt JW, Wood T, et al. Elective transfer of single fresh blastocysts and later transfer of cryostored blastocysts reduces the twin pregnancy rate and can improve the in vitro fertilization live birth rate in younger women. Fertil Steril 2005; 84:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/75\">",
"      Chang HJ, Lee JR, Jee BC, et al. Impact of blastocyst transfer on offspring sex ratio and the monozygotic twinning rate: a systematic review and meta-analysis. Fertil Steril 2009; 91:2381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/76\">",
"      Skiadas CC, Missmer SA, Benson CB, et al. Risk factors associated with pregnancies containing a monochorionic pair following assisted reproductive technologies. Hum Reprod 2008; 23:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/77\">",
"      Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol 2012; 120:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/78\">",
"      Dar S, Librach CL, Gunby J, et al. Increased risk of preterm birth in singleton pregnancies after blastocyst versus Day 3 embryo transfer: Canadian ART Register (CARTR) analysis. Hum Reprod 2013; 28:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/79\">",
"      Fernando D, Halliday JL, Breheny S, Healy DL. Outcomes of singleton births after blastocyst versus nonblastocyst transfer in assisted reproductive technology. Fertil Steril 2012; 97:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/80\">",
"      Papanikolaou EG, Kolibianakis EM, Tournaye H, et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod 2008; 23:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/81\">",
"      Racowsky C, Jackson KV, Cekleniak NA, et al. The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer. Fertil Steril 2000; 73:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/82\">",
"      Cruz JR, Dubey AK, Patel J, et al. Is blastocyst transfer useful as an alternative treatment for patients with multiple in vitro fertilization failures? Fertil Steril 1999; 72:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/83\">",
"      Milki AA, Hinckley MD, Fisch JD, et al. Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations. Fertil Steril 2000; 73:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/84\">",
"      Schoolcraft WB, Gardner DK. Blastocyst culture and transfer increases the efficiency of oocyte donation. Fertil Steril 2000; 74:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/85\">",
"      Balaban B, Urman B, Alatas C, et al. Blastocyst-stage transfer of poor-quality cleavage-stage embryos results in higher implantation rates. Fertil Steril 2001; 75:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/86\">",
"      Wilson M, Hartke K, Kiehl M, et al. Integration of blastocyst transfer for all patients. Fertil Steril 2002; 77:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/87\">",
"      Kissin DM, Schieve LA, Reynolds MA. Multiple-birth risk associated with IVF and extended embryo culture: USA, 2001. Hum Reprod 2005; 20:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/88\">",
"      Karaki RZ, Samarraie SS, Younis NA, et al. Blastocyst culture and transfer: a step toward improved in vitro fertilization outcome. Fertil Steril 2002; 77:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/89\">",
"      Scholtes MC, Zeilmaker GH. A prospective, randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization. Fertil Steril 1996; 65:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/90\">",
"      Gardner DK, Schoolcraft WB, Wagley L, et al. A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Hum Reprod 1998; 13:3434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/91\">",
"      Coskun S, Hollanders J, Al-Hassan S, et al. Day 5 versus day 3 embryo transfer: a controlled randomized trial. Hum Reprod 2000; 15:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/92\">",
"      Huisman GJ, Fauser BC, Eijkemans MJ, Pieters MH. Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture. Fertil Steril 2000; 73:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/93\">",
"      Levron J, Shulman A, Bider D, et al. A prospective randomized study comparing day 3 with blastocyst-stage embryo transfer. Fertil Steril 2002; 77:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/94\">",
"      Rienzi L, Ubaldi F, Iacobelli M, et al. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod 2002; 17:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/95\">",
"      Utsunomiya T, Naitou T, Nagaki M. A prospective trial of blastocyst culture and transfer. Hum Reprod 2002; 17:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/96\">",
"      Levitas E, Lunenfeld E, Har-Vardi I, et al. Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2-3 embryo transfer cycles: a prospective, randomized study. Fertil Steril 2004; 81:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/97\">",
"      Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine. Elective single-embryo transfer. Fertil Steril 2012; 97:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/98\">",
"      Gelbaya TA, Tsoumpou I, Nardo LG. The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis. Fertil Steril 2010; 94:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/99\">",
"      Vitthala S, Gelbaya TA, Brison DR, et al. The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis. Hum Reprod Update 2009; 15:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/100\">",
"      Fauque P, Jouannet P, Davy C, et al. Cumulative results including obstetrical and neonatal outcome of fresh and frozen-thawed cycles in elective single versus double fresh embryo transfers. Fertil Steril 2010; 94:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/101\">",
"      Kjellberg AT, Carlsson P, Bergh C. Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis. Hum Reprod 2006; 21:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/102\">",
"      Heijnen EM, Eijkemans MJ, De Klerk C, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 2007; 369:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/103\">",
"      Papanikolaou EG, Camus M, Kolibianakis EM, et al. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 2006; 354:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/104\">",
"      van Peperstraten A, Nelen W, Grol R, et al. The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial. BMJ 2010; 341:c2501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/105\">",
"      Grady R, Alavi N, Vale R, et al. Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis. Fertil Steril 2012; 97:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/106\">",
"      Jones, HW Jr. Multiple births: how are we doing? Fertil Steril 2002; 79:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/107\">",
"      Gleicher N, Oleske DM, Tur-Kaspa I, et al. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 2000; 343:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/108\">",
"      Dickey RP, Taylor SN, Lu PY, et al. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril 2005; 83:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/109\">",
"      Homburg R, Howles CM. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update 1999; 5:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/110\">",
"      Wang JX, Kwan M, Davies MJ, et al. Risk of multiple pregnancy when infertility is treated with ovulation induction by gonadotropins. Fertil Steril 2003; 80:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/111\">",
"      Albano C, Platteau P, Nogueira D, et al. Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicular reduction. Fertil Steril 2001; 76:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/112\">",
"      ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 34, February 2002. Management of infertility caused by ovulatory dysfunction. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99:347.",
"     </a>",
"    </li>",
"    <li>",
"     Royal College of Obstetricians and Gynaecologists. The initial investigation and management of the infertile couple. Evidence-based clinical guideline no. 2. Royal College of Obstetricians and Gynaecologists. 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/27/43449/abstract/114\">",
"      Dickey RP, Taylor SN, Lu PY, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol 2002; 186:77.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7417 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-190.92.87.104-2CE9AB38EC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43449=[""].join("\n");
var outline_f42_27_43449=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LIMITING THE MULTIPLE GESTATION RISK OF ART",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94578635\">",
"      Factors affecting multiple gestation risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Maternal age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Embryo quality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Number of eggs fertilized",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Preimplantation genetic screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Assessment of noninvasive biomarkers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Day of transfer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Day 2 or 3 (cleavage stage)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Day 5 (blastocyst stage)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Single embryo transfer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      LIMITING THE MULTIPLE GESTATION RISK OF OVULATION INDUCTION AND SUPEROVULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MULTIFETAL PREGNANCY REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/7417\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/7417|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/4/35904\" title=\"figure 1\">",
"      Preimplantation development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/7417|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/20/8524\" title=\"table 1\">",
"      Complications associated with multiple gestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/61/16347\" title=\"table 2\">",
"      Strategies to control the rate of high order multiple gestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/39/6780\" title=\"table 3\">",
"      ASRM revised guidelines for embryo transfer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/54/27499\" title=\"table 4\">",
"      Effect of maternal age and embryos transferred on outcome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/9/39065?source=related_link\">",
"      Multifetal pregnancy reduction and selective termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27594?source=related_link\">",
"      Neonatal outcome, complications, and management of multiple births",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/6/2154?source=related_link\">",
"      Pregnancy outcome after assisted reproductive technology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/56/23431?source=related_link\">",
"      Preimplantation genetic diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_27_43450="ECG in electrical alternans";
var content_f42_27_43450=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1184px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrical alternans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sinus tachycardia with electrical alternans which is characterized by beat-to-beat alternation in the QRS appearance (best seen in leads V2 to V4). These findings are strongly suggestive of pericardial effusion, usually with cardiac tamponade. The alternating ECG pattern is related to back-and-forth swinging motion of the heart in the pericardial fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43450=[""].join("\n");
var outline_f42_27_43450=null;
var title_f42_27_43451="Carb counting getting started";
var content_f42_27_43451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Carbohydrate counting: getting started",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Step 1: Know the goal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Eating about the same amount of carbohydrate at meals and snacks each day will help to keep blood glucose levels from getting too high or too low.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Focus on keeping the amount of carbohydrate intake moderate to keep your blood glucose levels from going too high. Remember, it is not healthy to cut out all carbohydrate foods; the body, especially your brain, needs some every day.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Step 2: Monitoring intake and blood glucose",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Keeping a daily food and blood glucose record will help inform what affects blood glucose levels.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Measuring or weighing foods is helpful in the beginning to learn what common food portions look like.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Step 3: Methods of counting carbohydrate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       To count carbohydrates, there are two methods. Patients may also blend the two methods.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Read food labels:",
"       </strong>",
"       Look at the grams of total carbohydrate on the label. Remember, the nutrition information on food labels is for the standard serving size. If the portion is larger or smaller, it is necessary to adjust the carbohydrate information.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Use the exchange system:",
"       </strong>",
"       Estimation of carbohydrate content can be broken down into food groups that are standardized for carbohydrate content according to particular portions. For example, one serving from the Bread/Starch, Fruit, or Milk group each contains between 12 and 15 grams of carbohydrate. Most vegetables do not contain a significant number of carbohydrates and do not need to be counted, although there are exceptions (eg, corn, potatoes).",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43451=[""].join("\n");
var outline_f42_27_43451=null;
var title_f42_27_43452="Clonidine and related imidazoline poisoning - Rapid overview";
var content_f42_27_43452=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clonidine and related imidazoline poisoning: Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptoms usually appear within 1 hour of oral ingestion of pills or liquids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delayed symptoms may be seen after clonidine transdermal patch exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        May mimic opioid intoxication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Common findings: lethargy, coma, bradycardia, hypotension, respiratory depression, apnea, small pupils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial evaluation: fingerstick blood glucose (if any alteration in mental status), 12-lead ECG, serum salicylate and acetaminophen levels (if suicidal attempt), pregnancy test (in women of childbearing age)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptomatic patients: arterial or venous pH and pCO",
"        <sub>",
"         2",
"        </sub>",
"        , serum electrolytes, BUN, creatinine, and chest radiograph if serious and persistent respiratory depression or coma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove any transdermal clonidine patches",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Support airway and breathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Respiratory depression or mental status depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Naloxone, 0.1 mg/kg (maximum single dose 2 mg; may repeat up to 10 mg total dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Symptomatic bradycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1st line: atropine, 0.02 mg/kg IV (minimum dose: 0.1 mg, maximum single dose: 1 mg), repeat every 5 minutes to maximum total dose: 0.04 mg/kg or 3 mg in adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2nd line: dopamine (initiate at 5-10 mcg/kg per minute to start, titrate to response; maximum dose 20 mcg/kg per minute)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Hypotension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1st line: crystalloid (intravenous normal saline or Ringer's lactate 20 mL/kg (maximum 1 L), up to 60 to 100 mL/kg (3 to 5 L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2nd line: dopamine (initiate at 5-10 mcg/kg per minute to start, titrate to response; maximum dose 20 mcg/kg per minute)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not treat asymptomatic hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Administer activated charcoal (AC), 1 gm/kg (maximum dose, 50 grams) to alert patients who present within 1 to 2 hours of ingestion unless contraindicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Administer AC 1 gm/kg (maximum dose, 50 grams) followed by whole bowel irrigation at 500 mL to 1 L per hour in alert patients who have ingested a clonidine transdermal patch unless contraindicated",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43452=[""].join("\n");
var outline_f42_27_43452=null;
var title_f42_27_43453="Transient ATN post AAA repair";
var content_f42_27_43453=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F67443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F67443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 572px\">",
"   <div class=\"ttl\">",
"    Serial changes in GFR after aortic aneurysm surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 552px; height: 213px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serial changes in glomerular filtration rate (GFR) after elective aortic aneurysm surgery involving an infrarenal clamp (left panel) or suprarenal clamp (right panel); the latter procedure was associated with 20 to 80 minutes of total renal ischemia. One to two hours after surgery with suprarenal clamping, there was a 60 percent reduction in GFR. By 24 hours, however, partial recovery had occurred and the GFR was almost normal by 48 hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Myers, BD, Miller, C, Mehigan, JT, et al, J Clin Invest 1984; 73:329.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43453=[""].join("\n");
var outline_f42_27_43453=null;
var title_f42_27_43454="Frequency of intracranial aneurysm rupture";
var content_f42_27_43454=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Graph showing risk of rupture of intracranial aneurysms among patients with and without history of prior subarachnoid hemorrhage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 458px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retrospective analysis of the probability of subarachnoid hemorrhage (SAH) over time in patients with an unruptured intracranial aneurysm: 446 without (top panel) and 438 with (bottom panel) a history of SAH from a different aneurysm. The results are shown according to the size of the aneurysm. The risk is clearly related to the size of the aneurysm in patients with no prior history of SAH, with aneurysms &lt;10 mm in size having a very low incidence of rupture. Such a relationship was not apparent in those with a prior history of SAH; the values are not shown for aneurysms &ge;25 mm in this group because of the small number of patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: The International Study of Unruptured Intracranial Aneurysms Investigators, N Engl J Med 1998; 339:1725.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43454=[""].join("\n");
var outline_f42_27_43454=null;
var title_f42_27_43455="Intragastric balloon";
var content_f42_27_43455=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F58305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F58305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Intragastric balloon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The intragastric balloon is a temporary alternative for weight loss in moderately obese individuals. It consists of a soft, saline-filled balloon placed endoscopically that promotes a feeling of satiety and restriction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jones DB, Schneider BE, Olbers T. Atlas of Metabolic and Weight Loss Surgery. Cine-Med, North Woodbury, Connecticut 2010. Copyright &copy; 2010 Cine-Med.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_27_43455=[""].join("\n");
var outline_f42_27_43455=null;
